TWI802101B - Compositions of red-fleshed apples and cherry plums and their use in lowering blood sugar - Google Patents
Compositions of red-fleshed apples and cherry plums and their use in lowering blood sugar Download PDFInfo
- Publication number
- TWI802101B TWI802101B TW110143996A TW110143996A TWI802101B TW I802101 B TWI802101 B TW I802101B TW 110143996 A TW110143996 A TW 110143996A TW 110143996 A TW110143996 A TW 110143996A TW I802101 B TWI802101 B TW I802101B
- Authority
- TW
- Taiwan
- Prior art keywords
- red
- apple
- cherry plum
- cherry
- fruit
- Prior art date
Links
- 235000009836 Prunus pissardii Nutrition 0.000 title claims abstract description 281
- 239000000203 mixture Substances 0.000 title claims abstract description 119
- 239000008280 blood Substances 0.000 title claims abstract description 42
- 210000004369 blood Anatomy 0.000 title claims abstract description 42
- 244000277586 Prunus pissardii Species 0.000 title abstract description 270
- 235000021016 apples Nutrition 0.000 title abstract description 82
- 244000141359 Malus pumila Species 0.000 title 1
- 241000220225 Malus Species 0.000 claims abstract description 287
- 239000000047 product Substances 0.000 claims abstract description 50
- 239000003814 drug Substances 0.000 claims abstract description 48
- 239000000843 powder Substances 0.000 claims abstract description 40
- 235000015203 fruit juice Nutrition 0.000 claims abstract description 25
- 239000002775 capsule Substances 0.000 claims abstract description 16
- 235000013305 food Nutrition 0.000 claims abstract description 12
- 239000003826 tablet Substances 0.000 claims abstract description 7
- 239000000284 extract Substances 0.000 claims description 136
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 70
- 235000013399 edible fruits Nutrition 0.000 claims description 69
- 239000007788 liquid Substances 0.000 claims description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 51
- 229940079593 drug Drugs 0.000 claims description 29
- 238000002390 rotary evaporation Methods 0.000 claims description 29
- 238000010009 beating Methods 0.000 claims description 25
- 235000009508 confectionery Nutrition 0.000 claims description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 25
- 206010012601 diabetes mellitus Diseases 0.000 claims description 19
- 230000002255 enzymatic effect Effects 0.000 claims description 19
- 201000010099 disease Diseases 0.000 claims description 18
- 238000003809 water extraction Methods 0.000 claims description 18
- 235000015094 jam Nutrition 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 14
- 235000020989 red meat Nutrition 0.000 claims description 14
- 239000013066 combination product Substances 0.000 claims description 11
- 229940127555 combination product Drugs 0.000 claims description 11
- 235000021022 fresh fruits Nutrition 0.000 claims description 10
- 235000013402 health food Nutrition 0.000 claims description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 8
- 229940123208 Biguanide Drugs 0.000 claims description 6
- 108010059892 Cellulase Proteins 0.000 claims description 6
- 235000004789 Rosa xanthina Nutrition 0.000 claims description 6
- 241000220222 Rosaceae Species 0.000 claims description 6
- 229940106157 cellulase Drugs 0.000 claims description 6
- 235000011869 dried fruits Nutrition 0.000 claims description 6
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 claims description 5
- 241000196324 Embryophyta Species 0.000 claims description 5
- 102000004877 Insulin Human genes 0.000 claims description 5
- 108090001061 Insulin Proteins 0.000 claims description 5
- 229940057037 cherry plum extract Drugs 0.000 claims description 5
- 235000019990 fruit wine Nutrition 0.000 claims description 5
- 229940125396 insulin Drugs 0.000 claims description 5
- 229940122199 Insulin secretagogue Drugs 0.000 claims description 4
- 229940122355 Insulin sensitizer Drugs 0.000 claims description 4
- 229940123518 Sodium/glucose cotransporter 2 inhibitor Drugs 0.000 claims description 4
- 229940100389 Sulfonylurea Drugs 0.000 claims description 4
- 229940090124 dipeptidyl peptidase 4 (dpp-4) inhibitors for blood glucose lowering Drugs 0.000 claims description 4
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 claims description 3
- 235000003840 Amygdalus nana Nutrition 0.000 claims description 2
- 241001528573 Malus niedzwetzkyana Species 0.000 claims description 2
- 241000220299 Prunus Species 0.000 claims description 2
- 235000011432 Prunus Nutrition 0.000 claims description 2
- 235000012970 cakes Nutrition 0.000 claims description 2
- 235000014774 prunus Nutrition 0.000 claims description 2
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 claims description 2
- 241001506873 Prunus cerasifera Species 0.000 claims 11
- 238000000527 sonication Methods 0.000 claims 2
- 239000012141 concentrate Substances 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 229940126585 therapeutic drug Drugs 0.000 claims 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 12
- 230000002195 synergetic effect Effects 0.000 abstract description 11
- 241000252212 Danio rerio Species 0.000 abstract description 4
- 241000699666 Mus <mouse, genus> Species 0.000 abstract description 2
- 238000002474 experimental method Methods 0.000 abstract description 2
- 239000012263 liquid product Substances 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 77
- 238000000605 extraction Methods 0.000 description 71
- 239000002994 raw material Substances 0.000 description 30
- 238000001914 filtration Methods 0.000 description 20
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 17
- 229960003105 metformin Drugs 0.000 description 17
- 238000000034 method Methods 0.000 description 16
- -1 etc.) Chemical compound 0.000 description 15
- 238000002386 leaching Methods 0.000 description 13
- JVHXJTBJCFBINQ-ADAARDCZSA-N Dapagliflozin Chemical compound C1=CC(OCC)=CC=C1CC1=CC([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC=C1Cl JVHXJTBJCFBINQ-ADAARDCZSA-N 0.000 description 11
- 229960003834 dapagliflozin Drugs 0.000 description 11
- 238000002137 ultrasound extraction Methods 0.000 description 10
- 239000007787 solid Substances 0.000 description 8
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 6
- 235000010094 aprium Nutrition 0.000 description 6
- 238000004108 freeze drying Methods 0.000 description 6
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 description 6
- 230000001629 suppression Effects 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 208000035475 disorder Diseases 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 235000014594 pastries Nutrition 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 3
- BOVGTQGAOIONJV-BETUJISGSA-N 1-[(3ar,6as)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]-3-(4-methylphenyl)sulfonylurea Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1C[C@H]2CCC[C@H]2C1 BOVGTQGAOIONJV-BETUJISGSA-N 0.000 description 3
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108010059820 Polygalacturonase Proteins 0.000 description 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 3
- 229960002632 acarbose Drugs 0.000 description 3
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 3
- 239000012675 alcoholic extract Substances 0.000 description 3
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 3
- 150000004283 biguanides Chemical class 0.000 description 3
- 208000033679 diabetic kidney disease Diseases 0.000 description 3
- 229960003345 empagliflozin Drugs 0.000 description 3
- OBWASQILIWPZMG-QZMOQZSNSA-N empagliflozin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=CC=C(Cl)C(CC=2C=CC(O[C@@H]3COCC3)=CC=2)=C1 OBWASQILIWPZMG-QZMOQZSNSA-N 0.000 description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 108010093305 exopolygalacturonase Proteins 0.000 description 3
- 229960004580 glibenclamide Drugs 0.000 description 3
- 229960000346 gliclazide Drugs 0.000 description 3
- 229960004346 glimepiride Drugs 0.000 description 3
- WIGIZIANZCJQQY-RUCARUNLSA-N glimepiride Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C=C1 WIGIZIANZCJQQY-RUCARUNLSA-N 0.000 description 3
- ZJJXGWJIGJFDTL-UHFFFAOYSA-N glipizide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZJJXGWJIGJFDTL-UHFFFAOYSA-N 0.000 description 3
- 229960001381 glipizide Drugs 0.000 description 3
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 229960005095 pioglitazone Drugs 0.000 description 3
- 229960004586 rosiglitazone Drugs 0.000 description 3
- 229960004937 saxagliptin Drugs 0.000 description 3
- QGJUIPDUBHWZPV-SGTAVMJGSA-N saxagliptin Chemical compound C1C(C2)CC(C3)CC2(O)CC13[C@H](N)C(=O)N1[C@H](C#N)C[C@@H]2C[C@@H]21 QGJUIPDUBHWZPV-SGTAVMJGSA-N 0.000 description 3
- 108010033693 saxagliptin Proteins 0.000 description 3
- 229960004034 sitagliptin Drugs 0.000 description 3
- MFFMDFFZMYYVKS-SECBINFHSA-N sitagliptin Chemical compound C([C@H](CC(=O)N1CC=2N(C(=NN=2)C(F)(F)F)CC1)N)C1=CC(F)=C(F)C=C1F MFFMDFFZMYYVKS-SECBINFHSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 244000007021 Prunus avium Species 0.000 description 2
- 235000010401 Prunus avium Nutrition 0.000 description 2
- 235000014441 Prunus serotina Nutrition 0.000 description 2
- FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229940009456 adriamycin Drugs 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 235000012754 curcumin Nutrition 0.000 description 2
- 239000004148 curcumin Substances 0.000 description 2
- 229940109262 curcumin Drugs 0.000 description 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000021018 plums Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229960001729 voglibose Drugs 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241001290151 Prunus avium subsp. avium Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 244000159501 Ximenia caffra Species 0.000 description 1
- 235000001365 Ximenia caffra Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/84—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/10—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products
- A23L21/12—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products derived from fruit or vegetable solids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
- A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Fruits And Vegetables (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本發明涉及食品和藥品領域,特別涉及具有降血糖功效的紅肉蘋果和櫻桃李組合物,該紅肉蘋果和櫻桃李的重量比為1:10至10:1。斑馬魚和小鼠動物實驗表明,紅肉蘋果和櫻桃李組合物在降血糖功效方面具有協同增效作用,組合物的降血糖功效優於單獨使用紅肉蘋果或櫻桃李。紅肉蘋果和櫻桃李組合物的產品形式包括果汁、果醬、凍乾粉、口服液產品、膠囊、片劑等。The invention relates to the fields of food and medicine, in particular to a composition of red-fleshed apples and cherry plums with the effect of lowering blood sugar. The weight ratio of the red-flesh apples and cherry plums is 1:10 to 10:1. Zebrafish and mouse animal experiments show that the composition of red-fleshed apples and cherry plums has a synergistic effect on hypoglycemic efficacy, and the hypoglycemic effect of the composition is better than that of red-fleshed apples or cherry plums alone. The product forms of the red flesh apple and cherry plum composition include fruit juice, jam, freeze-dried powder, oral liquid products, capsules, tablets and the like.
Description
本發明涉及食品和藥品領域,具體涉及紅肉蘋果和櫻桃李組合物及其在降血糖方面的應用。The invention relates to the fields of food and medicine, in particular to a composition of red-fleshed apples and cherry plums and their application in reducing blood sugar.
糖尿病是一組因胰島素絕對或相對分泌不足及(或)胰島素利用障礙引起的以高血糖為特徵的代謝性疾病。國際糖尿病聯盟(IDF)2017年統計資料顯示,中國成年人的糖尿病患病率為9.7%至11.6%,糖尿病患病人群約1.1億,居世界首位。Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia caused by absolute or relative insulin secretion deficiency and (or) insulin utilization disorder. Statistics from the International Diabetes Federation (IDF) in 2017 show that the prevalence of diabetes in Chinese adults ranges from 9.7% to 11.6%, and the number of people with diabetes is about 110 million, ranking first in the world.
目前尚無根治糖尿病的方法,臨床上用於治療糖尿病的藥物主要有磺脲類藥物(如格列吡嗪、格列美脲、格列齊特、格列苯脲等)、雙胍類藥物(二甲雙胍)、α-糖苷酶抑製劑(阿卡波糖、伏格列波糖)、胰島素增敏劑(羅格列酮、吡格列酮等)、胰島素促泌劑(苯甲酸衍生物)、DPP-4抑製劑(沙格列汀、西格列汀等)、SGLT-2抑製劑(達格列淨、恩格列淨等),此外還有胰島素治療方式。但降血糖治療共同的嚴重副作用為低血糖。α-糖苷酶抑製劑、雙胍類及胰島素增收劑單獨使用一般不會引起低血糖,但與其他藥物連用時仍可能發生。雙胍類的降糖藥對腸胃的傷害較大。因此有必要尋找效果好且無副作用的天然資源,以用於糖尿病的防治。At present, there is no cure for diabetes. The clinically used drugs for the treatment of diabetes mainly include sulfonylureas (such as glipizide, glimepiride, gliclazide, glibenclamide, etc.), biguanides ( Metformin), α-glucosidase inhibitors (acarbose, voglibose), insulin sensitizers (rosiglitazone, pioglitazone, etc.), insulin secretagogues (benzoic acid derivatives), DPP-4 Inhibitors (saxagliptin, sitagliptin, etc.), SGLT-2 inhibitors (dapagliflozin, empagliflozin, etc.), and insulin therapy. However, hypoglycemia is a common serious side effect of hypoglycemic therapy. α-Glucosidase inhibitors, biguanides and insulin-stimulating agents generally do not cause hypoglycemia when used alone, but it may still occur when used in combination with other drugs. Biguanide hypoglycemic drugs are more harmful to the stomach. Therefore, it is necessary to find natural resources with good effect and no side effects for the prevention and treatment of diabetes.
紅肉蘋果( Malus neidzwetzkyanaDieck)是薔薇科(Rosaceae)蘋果屬(Malus Mill)植物,其果實的果肉呈紅色,果實的顏色主要是由花色苷的積累造成的。目前世界各地有眾多紅肉蘋果品種,例如中國新疆的洪勳系列、美國的Robert Crab、日本的紅寶石甜、瑞士的紅色之愛(Redlove)等。紅肉蘋果各品種的花、枝葉顏色、果實大小、著色程度、口感風味等各不相同。新疆的紅肉蘋果在紅果肉蘋果屬植物起源中有著重要的地位。 Red flesh apple ( Malus neidzwetzkyana Dieck) is a Rosaceae (Rosaceae) Malus Mill plant. The flesh of its fruit is red, and the color of the fruit is mainly caused by the accumulation of anthocyanins. At present, there are many varieties of red-fleshed apples around the world, such as Hongxun series in Xinjiang, China, Robert Crab in the United States, Ruby Sweet in Japan, and Redlove in Switzerland. The flowers, branch and leaf colors, fruit size, coloring degree, taste and flavor of each variety of red flesh apple are different. Red-fleshed apples in Xinjiang play an important role in the origin of red-fleshed apples.
櫻桃李( Prunus cerasiferaEhrhart),俗稱野酸梅,薔薇科李屬,是世界上極為珍貴和罕見並瀕危滅絕的原始野生林果。據《中國樹木志》的記載和國家野生植物研究院的考證,野生櫻桃李僅發現在新疆天山山脈西部及高加索、小亞細亞山地生存,野生資源極為稀少。櫻桃李果實在我國新疆地區有著悠久的食用歷史,居住在天山大西溝的哈薩克族、蒙古族牧民飲食以牛羊肉為主,其人群中患高血脂、高血壓的人卻很少,這與牧民長期採摘野生櫻桃李製作果醬或將果實曬乾泡茶的使用習慣有關。櫻桃李包括多個品種,按照顏色分主要有黑果、紅果、紫果、紫黑果、黃果等。 Cherry plum ( Prunus cerasifera Ehrhart), commonly known as wild sour plum, belongs to the genus Prunus in the family Rosaceae. It is an extremely precious, rare and endangered original wild forest fruit in the world. According to the records of "Chinese Tree Records" and the research of the National Institute of Wild Plants, wild cherry plums are only found in the western part of the Tianshan Mountains in Xinjiang, the Caucasus, and the mountains of Asia Minor, and wild resources are extremely scarce. Cherry and plum fruits have a long history of eating in the Xinjiang region of my country. The Kazak and Mongolian herdsmen who live in Daxigou, Tianshan Mountains mainly eat beef and mutton, but few of them suffer from hyperlipidemia and high blood pressure. This is different from the herdsmen It is related to the habit of picking wild cherry plums for a long time to make jam or drying the fruits to make tea. Cherry plums include many varieties, and according to the color, they mainly include black fruit, red fruit, purple fruit, purple black fruit, yellow fruit and so on.
紅肉蘋果和櫻桃李富含多種氨基酸、維生素、礦物質,以及花色苷、多酚、類黃酮等功能成分,具有較高的開發價值。但目前的研究仍較有限,主要集中在化學成分及抗氧化方面,還處於初步研究階段。Red-fleshed apples and cherry plums are rich in various amino acids, vitamins, minerals, and functional components such as anthocyanins, polyphenols, and flavonoids, and have high development value. However, the current research is still relatively limited, mainly focusing on chemical components and antioxidant aspects, and is still in the preliminary research stage.
本申請發明人經過大量的實驗研究後發現,紅肉蘋果(或紅肉蘋果萃取物)和櫻桃李(或櫻桃李萃取物)的組合在降血糖方面具有協同增效作用。After a lot of experimental research, the inventors of the present application found that the combination of red-fleshed apples (or red-fleshed apple extracts) and cherry plums (or cherry plum extracts) has a synergistic effect on lowering blood sugar.
為此,在本發明的第一方面,本發明提供了組合物在製備藥物(如中藥、中成藥等)、普通食品或保健食品中的用途,該藥物(如中藥、中成藥等)、普通食品或保健食品用於降血糖或者用於預防及/或治療血糖性疾病,其中,該組合物包含: 第一組分,該第一組分為紅肉蘋果或紅肉蘋果萃取物;和 第二組分,該第二組分為櫻桃李或櫻桃李萃取物。 Therefore, in the first aspect of the present invention, the present invention provides the use of the composition in the preparation of medicine (such as traditional Chinese medicine, Chinese patent medicine, etc.), common food or health food, the medicine (such as Chinese medicine, Chinese patent medicine, etc.), common The food or health food is used for lowering blood sugar or for preventing and/or treating blood sugar diseases, wherein the composition comprises: a first component that is a red-fleshed apple or a red-fleshed apple extract; and The second component, the second component is cherry plum or cherry plum extract.
在一些實施方案中,該血糖性疾病選自糖尿病及糖尿病相關疾病(如I型糖尿病、II型糖尿病、糖尿病腎病等)。In some embodiments, the glycemic disease is selected from diabetes and diabetes-related diseases (such as type I diabetes, type II diabetes, diabetic nephropathy, etc.).
在一些實施方案中,該第一組分和該第二組分的重量比為1:10至10:1(如1:5-10:1、1:2-10:1、1:1-10:1、1:10-5:1、1:5-5:1、1:2-5:1、1:1-5:1、1:10-2:1、1:5-2:1、1:2-2:1、1:1-2:1、1:10-1:1、1:5-1:1、1:2-1:1、1:10-5:1、1:10-2:1、1:10-1:1、1:5-10:1、1:5-5:1、1:5-2:1、1:5-1:1、1:2-10:1、1:2-5:1、1:2-2:1、1:2-1:1、1:1-10:1、1:1-5:1、1:1-2:1,具體如1:5、1:2、1:1、2:1、5:1)。In some embodiments, the weight ratio of the first component to the second component is 1:10 to 10:1 (such as 1:5-10:1, 1:2-10:1, 1:1- 10:1, 1:10-5:1, 1:5-5:1, 1:2-5:1, 1:1-5:1, 1:10-2:1, 1:5-2: 1, 1:2-2:1, 1:1-2:1, 1:10-1:1, 1:5-1:1, 1:2-1:1, 1:10-5:1, 1:10-2:1, 1:10-1:1, 1:5-10:1, 1:5-5:1, 1:5-2:1, 1:5-1:1, 1:1: 2-10:1, 1:2-5:1, 1:2-2:1, 1:2-1:1, 1:1-10:1, 1:1-5:1, 1:1- 2:1, such as 1:5, 1:2, 1:1, 2:1, 5:1).
在一些實施方案中,該紅肉蘋果萃取物藉由以下萃取方式之一獲得:浸提萃取、酶解超音波萃取、超高壓萃取、次臨界萃取或其他萃取方式。In some embodiments, the red apple extract is obtained by one of the following extraction methods: leaching extraction, enzymatic ultrasonic extraction, ultra-high pressure extraction, subcritical extraction or other extraction methods.
在一些實施方案中,該櫻桃李萃取物藉由以下萃取方式之一獲得:浸提萃取、酶解超音波萃取、超高壓萃取、次臨界萃取或其他萃取方式。In some embodiments, the cherry plum extract is obtained by one of the following extraction methods: leaching extraction, enzymatic ultrasonic extraction, ultra-high pressure extraction, subcritical extraction or other extraction methods.
在一些實施方案中,該組合物是以鮮果、果汁、果醬、果粉(如凍乾粉)、糖果(如壓片糖果)、口服液、膠囊、片劑、果乾、果脯、果酒或糕點等形式存在的。換句話說,該組合物的產品形式可以是鮮果、果汁、果醬、果粉(如凍乾粉)、糖果(如壓片糖果)、口服液、膠囊、片劑、果乾、果脯、果酒或糕點等。也就是說,該組合物可以製成鮮果、果汁、果醬、果粉(如凍乾粉)、糖果(如壓片糖果)、口服液、膠囊、片劑、果乾、果脯、果酒或糕點等。In some embodiments, the composition is in the form of fresh fruit, fruit juice, jam, fruit powder (such as freeze-dried powder), candy (such as compressed candy), oral liquid, capsule, tablet, dried fruit, preserved fruit, fruit wine or pastry, etc. form exists. In other words, the product form of the composition can be fresh fruit, fruit juice, jam, fruit powder (such as freeze-dried powder), candy (such as compressed candy), oral liquid, capsule, tablet, dried fruit, preserved fruit, fruit wine or pastry wait. That is to say, the composition can be made into fresh fruit, fruit juice, jam, fruit powder (such as freeze-dried powder), candy (such as compressed candy), oral liquid, capsule, tablet, dried fruit, preserved fruit, fruit wine or pastry, etc.
在一些實施方案中,該紅肉蘋果是指果肉為紅色的薔薇科蘋果屬植物的果實。In some embodiments, the red-fleshed apple refers to the fruit of a plant of the genus Malus in the family Rosaceae with red flesh.
在一些實施方案中,該紅肉蘋果選自:洪勳1號(紅勳1號)、洪勳3號(紅勳3號)、洪勳6號(紅勳6號)、夏紅肉、黛紅、紅色之愛、Roberts Crab、紅之夢、紅寶石甜等。In some embodiments, the red meat apple is selected from: Hongxun No. 1 (Hongxun No. 1), Hongxun No. 3 (Hongxun No. 3), Hongxun No. 6 (Hongxun No. 6), Xia Hongrou, Dai Hong, Red Love, Roberts Crab, Red Dream, Ruby Sweet, etc.
在一些實施方案中,該櫻桃李選自櫻桃李紅果、櫻桃李黑果、櫻桃李紫果、櫻桃李紫黑果、櫻桃李黃果等。In some embodiments, the cherry plum is selected from the group consisting of red fruit of plum cherry, black fruit of plum cherry, purple fruit of plum cherry, purple black fruit of plum cherry, yellow fruit of plum cherry, and yellow fruit of plum cherry.
在本發明的第二方面,本發明提供了組合產品,其包括: 第一產品,該第一產品為前述的組合物; 第二產品,該第二產品為預防及/或治療血糖性疾病的藥物。 In a second aspect of the present invention, the present invention provides a combination product comprising: A first product, the first product being the aforementioned composition; The second product, the second product is a drug for preventing and/or treating blood sugar disorders.
在一些實施方案中,該血糖性疾病選自糖尿病及糖尿病相關疾病(如I型糖尿病、II型糖尿病、糖尿病腎病等)。In some embodiments, the glycemic disease is selected from diabetes and diabetes-related diseases (such as type I diabetes, type II diabetes, diabetic nephropathy, etc.).
在一些實施方案中,該預防及/或治療血糖性疾病的藥物選自磺脲類藥物(如格列吡嗪、格列美脲、格列齊特、格列苯脲等)、雙胍類藥物(二甲雙胍)、α-糖苷酶抑製劑(阿卡波糖、伏格列波糖)、胰島素增敏劑(羅格列酮、吡格列酮等)、胰島素促泌劑(苯甲酸衍生物)、DPP-4抑製劑(沙格列汀、西格列汀等)、SGLT-2抑製劑(達格列淨、恩格列淨等)、胰島素等。In some embodiments, the drug for preventing and/or treating blood sugar disorders is selected from sulfonylurea drugs (such as glipizide, glimepiride, gliclazide, glibenclamide, etc.), biguanide drugs (Metformin), α-glucosidase inhibitors (acarbose, voglibose), insulin sensitizers (rosiglitazone, pioglitazone, etc.), insulin secretagogues (benzoic acid derivatives), DPP- 4 Inhibitors (saxagliptin, sitagliptin, etc.), SGLT-2 inhibitors (dapagliflozin, empagliflozin, etc.), insulin, etc.
在一些實施方案中,該第一產品和該第二產品(如二甲雙胍或達格列淨)的重量比為20000:0.75至20000:600(如20000:0.75、20000:1.5、20000:2、20000:2.5、20000:3、20000:3.5、20000:4、20000:4.5、20000:5、20000:5.5、20000:6、20000:75、20000:150、20000:200、20000:250、20000:300、20000:350、20000:400、20000:450、20000:500、20000:550、20000:600;或者如20000:1.5至20000:300;或者如20000:150至20000:300,具體如20000:150、20000:200、20000:250或20000:300;或者如20000:1.5至20000:3,具體如20000:1.5、20000:2、20000:2.5或20000:3)。In some embodiments, the weight ratio of the first product to the second product (such as metformin or dapagliflozin) is 20000:0.75 to 20000:600 (such as 20000:0.75, 20000:1.5, 20000:2, 20000 : 2.5, 20000: 3, 20000: 3.5, 20000: 4, 20000: 4.5, 20000: 5, 20000: 5.5, 20000: 6, 20000: 75, 20000: 150, 20000: 200, 20000: 250, 20000: 300 . .
在一些實施方案中,該第二產品為二甲雙胍時,該第一產品和該第二產品的重量比為20000:75至20000:600(如20000:75、20000:150、20000:200、20000:250、20000:300、20000:350、20000:400、20000:450、20000:500、20000:550、20000:600;或者如20000:150至20000:300,具體如20000:150、20000:200、20000:250、20000:300)。In some embodiments, when the second product is metformin, the weight ratio of the first product to the second product is 20000:75 to 20000:600 (such as 20000:75, 20000:150, 20000:200, 20000: 250, 20000: 300, 20000: 350, 20000: 400, 20000: 450, 20000: 500, 20000: 550, 20000: 600; 20000: 250, 20000: 300).
在一些實施方案中,該第二產品為達格列淨時,該第一產品和該第二產品的重量比為20000:0.75至20000:6(如20000:0.75、20000:1.5、20000:2、20000:2.5、20000:3、20000:3.5、20000:4、20000:4.5、20000:5、20000:5.5、20000:6;或者如20000:1.5至20000:3,具體如20000:1.5、20000:2、20000:2.5、20000:3)。In some embodiments, when the second product is dapagliflozin, the weight ratio of the first product to the second product is 20000:0.75 to 20000:6 (such as 20000:0.75, 20000:1.5, 20000:2 , 20000: 2.5, 20000: 3, 20000: 3.5, 20000: 4, 20000: 4.5, 20000: 5, 20000: 5.5, 20000: 6; : 2, 20000: 2.5, 20000: 3).
在本發明的第三方面,本發明提供了前述的組合產品在製備藥物(如中藥、中成藥等)、普通食品或保健食品中的用途,該藥物(如中藥、中成藥等)、普通食品或保健食品用於降血糖,或者用於預防及/或治療血糖性疾病。In the third aspect of the present invention, the present invention provides the use of the aforementioned combination product in the preparation of medicine (such as traditional Chinese medicine, Chinese patent medicine, etc.), common food or health food. Or health food is used for lowering blood sugar, or used for preventing and/or treating blood sugar disease.
在本發明的第四方面,本發明提供了前述的組合物或前述的組合產品,其用於降血糖,或者用於預防及/或治療血糖性疾病。In the fourth aspect of the present invention, the present invention provides the aforementioned composition or the aforementioned combination product, which is used for lowering blood sugar, or used for preventing and/or treating blood sugar disorders.
在本發明的第五方面,本發明提供了降血糖,或者預防及/或治療血糖性疾病的方法,其包括給有此需要的個體服用前述的組合物或前述的組合產品。In the fifth aspect of the present invention, the present invention provides a method for lowering blood sugar, or preventing and/or treating blood sugar disorders, which comprises administering the aforementioned composition or the aforementioned combination product to individuals in need thereof.
在一些實施方案中,上述血糖性疾病選自糖尿病及糖尿病相關疾病(如I型糖尿病、II型糖尿病、糖尿病腎病等)。In some embodiments, the above-mentioned blood sugar disease is selected from diabetes and diabetes-related diseases (such as type I diabetes, type II diabetes, diabetic nephropathy, etc.).
另外,本發明還揭露了降血糖的紅肉蘋果和櫻桃李組合產品及其製備方法,包括鮮果、果汁、果醬、凍乾粉、壓片糖果、口服液、膠囊等產品形式。動物實驗表明,該系列產品具有很好的協同降血糖效果。在某些實施例中,本發明的組合物還可用於製備中藥、中成藥等藥物。In addition, the present invention also discloses a hypoglycemic combination product of red-fleshed apples and cherry plums and a preparation method thereof, including fresh fruit, fruit juice, jam, freeze-dried powder, compressed candy, oral liquid, capsules and other product forms. Animal experiments have shown that this series of products has a good synergistic hypoglycemic effect. In some embodiments, the composition of the present invention can also be used to prepare traditional Chinese medicines, Chinese patent medicines and other medicines.
另外,在一個方面,本申請還提供了一種組合產品,其包含獨立包裝的第一產品和第二產品,該第一產品為紅肉蘋果和櫻桃李組合產品,該第二產品為降血糖藥物(例如磺脲類藥物(如格列吡嗪、格列美脲、格列齊特、格列苯脲等)、雙胍類藥物(二甲雙胍)、α-糖苷酶抑製劑(阿卡波糖、伏格列波糖)、胰島素增敏劑(羅格列酮、吡格列酮等)、胰島素促泌劑(苯甲酸衍生物)、DPP-4抑製劑(沙格列汀、西格列汀等)、SGLT-2抑製劑(達格列淨、恩格列淨等)、胰島素等)。In addition, in one aspect, the present application also provides a combination product, which includes a first product and a second product packaged independently, the first product is a combination product of red apples and cherry plums, and the second product is a hypoglycemic drug (such as sulfonylureas (such as glipizide, glimepiride, gliclazide, glibenclamide, etc.), biguanides (metformin), α-glucosidase inhibitors (acarbose, voltaic acid, etc.) Glibose), insulin sensitizers (rosiglitazone, pioglitazone, etc.), insulin secretagogues (benzoic acid derivatives), DPP-4 inhibitors (saxagliptin, sitagliptin, etc.), SGLT -2 inhibitors (dapagliflozin, empagliflozin, etc.), insulin, etc.).
本發明中,“個體”包括人或非人動物。範例性人個體包括患有疾病(例如本文所述的疾病)的人個體(稱為患者)或正常個體。本發明中“非人動物”包括所有脊椎動物,例如非哺乳動物(例如魚類、鳥類、兩棲動物、爬行動物)和哺乳動物,例如非人靈長類、家畜及/或馴化動物(例如鼠、綿羊、犬、貓、乳牛、豬等)。In the present invention, "individual" includes human or non-human animal. Exemplary human subjects include human subjects suffering from a disease (eg, a disease described herein) (referred to as a patient) or normal subjects. "Non-human animals" in the present invention include all vertebrates, such as non-mammals (such as fish, birds, amphibians, reptiles) and mammals, such as non-human primates, livestock and/or domesticated animals (such as mice, sheep, dogs, cats, cows, pigs, etc.).
本發明中,“櫻桃李萃取物”或者“紅肉蘋果萃取物”是指以櫻桃李或紅肉蘋果為原料,經過物理及/或化學萃取分離過程,獲取和富集櫻桃李或紅肉蘋果中的一種或多種有效成分而形成的產物,其可以作為食品(例如普通食品或保健食品)或藥品的原料或輔料。範例性的萃取方式包括但不限於:浸提萃取、酶解超音波萃取、超高壓萃取和次臨界萃取。In the present invention, "cherry plum extract" or "red-flesh apple extract" refers to the extraction and enrichment of cherry plum or red-flesh apples through physical and/or chemical extraction and separation processes using cherry plums or red-flesh apples as raw materials It is a product formed by one or more active ingredients, which can be used as the raw material or auxiliary material of food (such as general food or health food) or medicine. Exemplary extraction methods include, but are not limited to: leaching extraction, enzymatic ultrasonic extraction, ultra-high pressure extraction and subcritical extraction.
以下提供範例性的製備紅肉蘋果和櫻桃李萃取物的方法。 浸提萃取 Exemplary methods of preparing red-fleshed apple and cherry plum extracts are provided below. Extraction
在某些實施方案中,本發明的紅肉蘋果和櫻桃李萃取物藉由浸提萃取(例如水浸提或醇浸提萃取)得到。In certain embodiments, the red-fleshed apple and cherry plum extracts of the present invention are obtained by leaching extraction (eg, water leaching or alcohol leaching extraction).
在某些實施方案中,該浸提萃取包括以下步驟: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿,直接獲得果漿,或者分離出果汁和果渣;在某些實施方案中,利用紗布(例如100至300目紗布,例如200目紗布)過濾分離出果汁和果渣; 步驟2:將果漿或者果渣與萃取介質(例如水或乙醇)混合,在常溫或加熱(例如,10-100℃,例如50℃)條件下萃取(例如萃取30-100min,例如60min),過濾得到果漿或果渣萃取液;在某些實施方案中,果漿或果渣與萃取介質以1:(2-10)(例如1:5)的重量比混合;在某些實施方案中,該乙醇為50%至95%的乙醇; 步驟3:將果漿萃取液或者果汁與果渣萃取液的合併液進行濃縮,得到紅肉蘋果和櫻桃李的浸提萃取物;在某些實施方案中,藉由旋轉蒸發進行濃縮;在某些實施方案中,旋轉蒸發的溫度為30-60℃,例如50℃; 步驟4:將萃取得到的紅肉蘋果和櫻桃李萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行萃取。 In certain embodiments, the leaching extraction comprises the steps of: Step 1: Deseeding or pitting red apples and cherry plums, respectively, to obtain pulp directly, or to separate juice and pomace; in some embodiments, using gauze (such as 100 to 300 mesh gauze, such 200 mesh gauze) to filter and separate the juice and pomace; Step 2: Mix the fruit pulp or pomace with the extraction medium (such as water or ethanol), and extract at normal temperature or heating (for example, 10-100°C, such as 50°C) (for example, extract for 30-100min, such as 60min), Filtration to obtain a pulp or pomace extract; in certain embodiments, the pulp or pomace is mixed with the extraction medium in a weight ratio of 1:(2-10) (eg, 1:5); in some embodiments , the ethanol is 50% to 95% ethanol; Step 3: Concentrating the fruit pulp extract or the combined liquid of the fruit juice and the pomace extract to obtain extracts of red-fleshed apples and cherry plums; in some embodiments, concentrating by rotary evaporation; In some embodiments, the temperature of the rotary evaporation is 30-60°C, such as 50°C; Step 4: Mix the extracted red flesh apple and cherry plum extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10: 1) Prepare a composition, or in step 1, mix the raw materials of red flesh apple and cherry plum according to the above-mentioned different ratios, and then extract.
在某些實施方案中,本發明的紅肉蘋果和櫻桃李萃取物藉由水浸提萃取得到,在某些實施方案中,該水浸提萃取包括以下步驟: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿,直接獲得果漿,或者用100至300目紗布過濾果汁,製得紅肉蘋果和櫻桃李果汁,分離果汁和果渣;在某些實施方案中,該紗布的目數選取200目; 步驟2:紅肉蘋果和櫻桃李果漿或者果渣按料液比1:(2-10)與水混合,10-100℃浸提萃取30-100min,過濾製得果漿或果渣萃取液;在某些實施方案中,該料液比選取1:5;在某些實施方案中,浸提萃取溫度選取50℃;在某些實施方案中,萃取時間選取60min; 步驟3:紅肉蘋果和櫻桃李果漿萃取液或果汁與果渣萃取液的合併液,在30-60℃旋轉蒸發濃縮,製得紅肉蘋果和櫻桃李水浸提萃取物;在某些實施方案中,旋轉蒸發溫度選取50℃; 步驟4:將萃取得到的紅肉蘋果和櫻桃李水浸提萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行萃取。 In certain embodiments, the red-fleshed apple and cherry plum extracts of the present invention are obtained by water leaching extraction, and in some embodiments, the water leaching extraction comprises the following steps: Step 1: Deseeding or pitting the red-fleshed apples and cherry plums respectively, and beating to obtain pulp directly, or filtering the juices with 100 to 300 mesh gauze to obtain red-flesh apples and cherry plum juices, and separating the juice and pomace; In some embodiments, the mesh number of the gauze is selected as 200 mesh; Step 2: Red meat apple and cherry plum pulp or pomace is mixed with water according to the ratio of material to liquid: (2-10), leached and extracted at 10-100°C for 30-100min, and filtered to obtain pulp or pomace extract ; In some embodiments, the solid-liquid ratio is selected as 1:5; in some embodiments, the leaching extraction temperature is selected at 50°C; in some embodiments, the extraction time is selected for 60 minutes; Step 3: red flesh apple and cherry plum pulp extract or the combined solution of juice and pomace extract, concentrated by rotary evaporation at 30-60 ° C to obtain red flesh apple and cherry plum water extract; in some In an embodiment, the rotary evaporation temperature is selected at 50°C; Step 4: Mix the extracted red flesh apple and cherry plum water extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1 , 10:1) to prepare a composition, or in step 1, mix the raw materials of red flesh apple and cherry plum according to the aforementioned different ratios, and then extract.
在某些實施方案中,本發明的紅肉蘋果和櫻桃李萃取物藉由醇浸提萃取得到,在某些實施方案中,該醇浸提萃取包括以下步驟: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿,直接獲得果漿,或者用100至300目紗布過濾果汁,製得紅肉蘋果和櫻桃李果汁,分離果汁和果渣;在某些實施方案中,該紗布的目數選取200目; 步驟2:紅肉蘋果和櫻桃李果漿或者果渣按料液比1:(2-10)與50%至95%的乙醇混合,10-100℃浸提萃取30-100min,過濾製得果漿或果渣萃取液;在某些實施方案中,該料液比選取1:5;在某些實施方案中,所使用的乙醇的濃度為50%;在某些實施方案中,浸提萃取溫度選取50℃;在某些實施方案中,萃取時間選取60min; 步驟3:紅肉蘋果和櫻桃李果漿萃取液或果汁與果渣萃取液的合併液,在30-60℃旋轉蒸發濃縮,果漿萃取液直接濃縮,製得紅肉蘋果和櫻桃李醇浸提萃取物;在某些實施方案中,旋轉蒸發溫度選取50℃;任選地,對萃取物進行揮乾處理以除去其中殘留的乙醇; 步驟4:將萃取得到的紅肉蘋果和櫻桃李醇浸提萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行萃取。 酶解超音波萃取 In certain embodiments, the red-fleshed apple and cherry plum extracts of the present invention are extracted by alcoholic extraction. In certain embodiments, the alcoholic extraction comprises the following steps: Step 1: Deseeding or pitting the red-fleshed apples and cherry plums respectively, and beating to obtain pulp directly, or filtering the juices with 100 to 300 mesh gauze to obtain red-flesh apples and cherry plum juices, and separating the juice and pomace; In some embodiments, the mesh number of the gauze is selected as 200 mesh; Step 2: Red meat apple and cherry plum pulp or pomace is mixed with 50% to 95% ethanol according to the ratio of material to liquid: (2-10), extracted at 10-100°C for 30-100min, and filtered to obtain fruit pulp or pomace extract; in some embodiments, the ratio of solid to liquid is selected as 1:5; in some embodiments, the concentration of ethanol used is 50%; in some embodiments, leaching extraction The temperature is selected as 50°C; in some embodiments, the extraction time is selected as 60min; Step 3: Red-flesh apple and cherry plum pulp extract or the combined liquid of juice and pomace extract is concentrated by rotary evaporation at 30-60°C, and the fruit pulp extract is directly concentrated to obtain red-flesh apple and cherry plum alcohol dip Extract the extract; in some embodiments, the rotary evaporation temperature is selected at 50° C.; optionally, the extract is evaporated to remove residual ethanol; Step 4: Mix the extracted red-flesh apple and cherry plum alcohol extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1 , 10:1) to prepare a composition, or in step 1, mix the raw materials of red flesh apple and cherry plum according to the aforementioned different ratios, and then extract. Enzymatic Ultrasonic Extraction
在某些實施方案中,本發明的紅肉蘋果和櫻桃李萃取物藉由酶解超音波萃取(例如酶解超音波水萃取或酶解超音波醇萃取)得到。In certain embodiments, the red-fleshed apple and cherry plum extracts of the present invention are obtained by enzymatic ultrasonic extraction (eg, enzymatic ultrasonic water extraction or enzymatic ultrasonic alcohol extraction).
在某些實施方案中,該酶解超音波萃取包括以下步驟: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿,直接獲得果漿,或者分離出果汁和果渣;在某些實施方案中,利用紗布(例如100至300目紗布,例如200目紗布)過濾分離出果汁和果渣; 步驟2:將果漿或果渣與萃取介質(例如水或乙醇)和纖維素酶混合,在加熱條件(例如30-50℃,例如45℃)下萃取(例如萃取30-100min,例如60min),繼而在超音波條件(例如100-500W的超音波功率)下超音波(例如超音波20-60min,例如超音波30min),過濾得到果漿或果渣萃取液;在某些實施方案中,纖維素酶的添加量(以果渣或果漿重量為基準)為0.2%至1%(例如0.5%);在某些實施方案中,果漿或果渣與萃取介質以1:(2-10)(例如1:5)的重量比混合;在某些實施方案中,該乙醇為50%至95%的乙醇; 步驟3:將紅肉蘋果和櫻桃李果漿萃取液或果汁與果渣萃取液的合併液進行濃縮,得到紅肉蘋果和櫻桃李的酶解超音波萃取物;在某些實施方案中,藉由旋轉蒸發進行濃縮;在某些實施方案中,旋轉蒸發的溫度為30-60℃,例如50℃; 步驟4:將萃取得到的紅肉蘋果和櫻桃李酶解超音波萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行萃取。 In certain embodiments, the enzymatic ultrasonic extraction comprises the steps of: Step 1: Deseeding or pitting red apples and cherry plums, respectively, to obtain pulp directly, or to separate juice and pomace; in some embodiments, using gauze (such as 100 to 300 mesh gauze, such 200 mesh gauze) to filter and separate the juice and pomace; Step 2: Mix fruit pulp or pomace with extraction medium (such as water or ethanol) and cellulase, and extract under heating conditions (such as 30-50°C, such as 45°C) (such as extraction for 30-100min, such as 60min) , and then under ultrasonic conditions (such as 100-500W ultrasonic power), ultrasonic (for example, ultrasonic 20-60min, such as ultrasonic 30min), filtered to obtain fruit pulp or pomace extract; in some embodiments, The amount of cellulase added (based on the weight of pomace or pulp) is 0.2% to 1% (eg 0.5%); in some embodiments, the ratio of pulp or pomace to extraction medium is 1:(2- 10) mixing in a weight ratio (eg 1:5); in certain embodiments, the ethanol is 50% to 95% ethanol; Step 3: concentrating red-flesh apple and cherry plum pulp extracts or the combined liquid of juice and pomace extracts to obtain enzymatic ultrasonic extracts of red-flesh apples and cherry plums; in some embodiments, by Concentrating by rotary evaporation; in some embodiments, the temperature of the rotary evaporation is 30-60°C, such as 50°C; Step 4: Mix the extracted red flesh apple and cherry plum enzymatic ultrasonic extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5: 1. 10:1) is prepared into a composition, or in step 1, the raw materials of red flesh apple and cherry plum are mixed according to the aforementioned different ratios, and then extracted.
在某些實施方案中,本發明的紅肉蘋果和櫻桃李萃取物藉由酶解超音波水萃取得到,在某些實施方案中,該酶解超音波水萃取包括以下步驟: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿,直接獲得果漿,或者用100至300目紗布過濾果汁,製得紅肉蘋果和櫻桃李果汁,分離果汁和果渣;在某些實施方案中,該紗布的目數選取200目; 步驟2:將紅肉蘋果和櫻桃李果漿或果渣按料液比1:(2-10)與水混合,添加0.2%至1%(以果渣或果漿重量為基準)的纖維素酶,30-50℃水浴萃取30-100min,100-500W超音波20-60min,過濾製得果漿或果渣萃取液;在某些實施方案中,料液比選取1:5;在某些實施方案中,纖維素酶添加量為0.5%;在某些實施方案中,水浴溫度為45℃;在某些實施方案中,萃取時間選取60min;在某些實施方案中,超音波功率為500W;在某些實施方案中,超音波時間為30min; 步驟3:紅肉蘋果和櫻桃李果漿或果汁與果渣萃取液的合併液,在30-60℃旋轉蒸發濃縮,製得紅肉蘋果和櫻桃李酶解超音波萃取水萃取物;在某些實施方案中,旋轉蒸發溫度選取50℃; 步驟4:將萃取得到的紅肉蘋果和櫻桃李酶解超音波水萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行萃取。 In some embodiments, the red-fleshed apple and cherry plum extracts of the present invention are obtained by enzymatic ultrasonic water extraction. In some embodiments, the enzymatic ultrasonic water extraction includes the following steps: Step 1: Deseeding or pitting the red-fleshed apples and cherry plums respectively, and beating to obtain pulp directly, or filtering the juices with 100 to 300 mesh gauze to obtain red-flesh apples and cherry plum juices, and separating the juice and pomace; In some embodiments, the mesh number of the gauze is selected as 200 mesh; Step 2: Mix red flesh apple and cherry plum pulp or pomace with water according to the ratio of material to liquid 1: (2-10), add 0.2% to 1% (based on the weight of pomace or pulp) of cellulose Enzyme, 30-50°C water bath extraction for 30-100min, 100-500W ultrasonic wave for 20-60min, filter to obtain fruit pulp or pomace extract; in some embodiments, the ratio of solid to liquid is selected as 1:5; in some In some embodiments, the added amount of cellulase is 0.5%; in some embodiments, the water bath temperature is 45°C; in some embodiments, the extraction time is 60min; in some embodiments, the ultrasonic power is 500W ; In certain embodiments, the ultrasound time is 30 minutes; Step 3: Red flesh apple and cherry plum pulp or the combined liquid of fruit juice and pomace extract is concentrated by rotary evaporation at 30-60°C to obtain red flesh apple and cherry plum enzymolysis ultrasonic extraction water extract; In some embodiments, the rotary evaporation temperature is selected at 50°C; Step 4: Mix the extracted red flesh apple and cherry plum enzymolysis ultrasonic water extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5 : 1, 10: 1) to prepare a composition, or in step 1, mix the raw materials of red flesh apple and cherry plum according to the aforementioned different ratios, and then extract.
在某些實施方案中,本發明的紅肉蘋果和櫻桃李萃取物藉由酶解超音波醇萃取得到,在某些實施方案中,該酶解超音波醇萃取包括以下步驟: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿,直接獲得果漿,或者用100至300目紗布過濾果汁,製得紅肉蘋果和櫻桃李果汁,分離果汁和果渣;在某些實施方案中,該紗布的目數選取200目; 步驟2:將紅肉蘋果和櫻桃李果漿或果渣按料液比1:(2-10)與50%至95%的乙醇混合,添加0.2%至1%(以果渣或果漿重量為基準)的纖維素酶,30-50℃水浴萃取30-100min,100-500W超音波20-60min,過濾製得果漿或果渣萃取液;在某些實施方案中,料液比選取1:5;在某些實施方案中,所使用的乙醇的濃度為50%;在某些實施方案中,纖維素酶添加量為0.5%;在某些實施方案中,水浴溫度為45℃;在某些實施方案中,萃取時間選取60min;在某些實施方案中,超音波功率為500W;在某些實施方案中,超音波時間為30min; 步驟3:紅肉蘋果和櫻桃李果漿萃取液或果汁與果渣萃取液的合併液,在30-60℃旋轉蒸發濃縮,製得紅肉蘋果和櫻桃李酶解超音波萃取醇萃取物;在某些實施方案中,旋轉蒸發溫度選取50℃;任選地,對萃取物進行揮乾處理以除去其中殘留的乙醇; 步驟4:將萃取得到的紅肉蘋果和櫻桃李酶解超音波醇萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行萃取。 超高壓萃取 In some embodiments, the red-flesh apple and cherry plum extracts of the present invention are obtained by enzymatic ultrasonic alcohol extraction. In some embodiments, the enzymatic ultrasonic alcohol extraction includes the following steps: Step 1: Deseeding or pitting the red-fleshed apples and cherry plums respectively, and beating to obtain pulp directly, or filtering the juices with 100 to 300 mesh gauze to obtain red-flesh apples and cherry plum juices, and separating the juice and pomace; In some embodiments, the mesh number of the gauze is selected as 200 mesh; Step 2: Mix red flesh apple and cherry plum pulp or pomace with 50% to 95% ethanol according to the ratio of material to liquid 1: (2-10), add 0.2% to 1% (by weight of pomace or pulp 30-50°C water bath extraction for 30-100min, 100-500W ultrasonic wave for 20-60min, and filter to obtain pulp or pomace extract; in some embodiments, the ratio of solid to liquid is selected as 1 : 5; in some embodiments, the concentration of ethanol used is 50%; in some embodiments, the cellulase addition amount is 0.5%; in some embodiments, the water bath temperature is 45 ℃; In some embodiments, the extraction time is 60min; in some embodiments, the ultrasonic power is 500W; in some embodiments, the ultrasonic time is 30min; Step 3: Red-flesh apple and cherry plum pulp extract or the combined liquid of juice and pomace extract is concentrated by rotary evaporation at 30-60°C to obtain red-flesh apple and cherry plum enzymolysis ultrasonic extraction alcohol extract; In some embodiments, the rotary evaporation temperature is selected at 50° C.; optionally, the extract is evaporated to remove residual ethanol; Step 4: Mix the extracted red flesh apple and cherry plum enzymolysis ultrasonic alcohol extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5 : 1, 10: 1) to prepare a composition, or in step 1, mix the raw materials of red flesh apple and cherry plum according to the aforementioned different ratios, and then extract. Ultra-high pressure extraction
在某些實施方案中,本發明的紅肉蘋果和櫻桃李萃取物藉由超高壓萃取(例如超高壓水萃取或超高壓醇萃取)得到。如本文中使用的,“超高壓”指的是壓強超過100 MPa(相當於1000個大氣壓)。In certain embodiments, the red-fleshed apple and cherry plum extracts of the present invention are obtained by ultra-high pressure extraction (eg, ultra-high pressure water extraction or ultra-high pressure alcohol extraction). As used herein, "ultrahigh pressure" refers to pressures in excess of 100 MPa (equivalent to 1000 atmospheres).
在某些實施方案中,該超高壓萃取包括以下步驟: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿,直接獲得果漿,或者分離出果汁和果渣;在某些實施方案中,利用紗布(例如100至300目紗布,例如200目紗布)過濾分離出果汁和果渣; 步驟2:將果漿或果渣與萃取介質(例如水或乙醇)混合,在超高壓(例如200-600MPa,例如400MPa)條件下處理(例如處理3-10min,例如處理5min),過濾得到果漿或果渣萃取液;在某些實施方案中,果漿或果渣與萃取介質以1:(2-10)(例如1:5)的重量比混合;在某些實施方案中,該乙醇為50%至95%的乙醇; 步驟3:將紅肉蘋果和櫻桃李果漿或果汁與果渣萃取液的合併液進行濃縮,得到紅肉蘋果和櫻桃李的超高壓萃取物;在某些實施方案中,藉由旋轉蒸發進行濃縮;在某些實施方案中,旋轉蒸發的溫度為30-60℃,例如50℃; 步驟4:將萃取得到的紅肉蘋果和櫻桃李超高壓萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行萃取。 In certain embodiments, the ultrahigh pressure extraction comprises the steps of: Step 1: Deseeding or pitting red apples and cherry plums, respectively, to obtain pulp directly, or to separate juice and pomace; in some embodiments, using gauze (such as 100 to 300 mesh gauze, such 200 mesh gauze) to filter and separate the juice and pomace; Step 2: Mix the fruit pulp or pomace with the extraction medium (such as water or ethanol), treat it under ultra-high pressure (such as 200-600MPa, such as 400MPa) (such as 3-10min, such as 5min), and filter to obtain fruit pulp or pomace extract; in certain embodiments, the pulp or pomace is mixed with the extraction medium in a weight ratio of 1:(2-10), such as 1:5; in some embodiments, the ethanol 50% to 95% ethanol; Step 3: Concentrating red-fleshed apple and cherry plum pulp or a combined liquid juice and pomace extract to obtain an ultra-high pressure extract of red-fleshed apple and cherry plum; in certain embodiments, by rotary evaporation Concentrating; in some embodiments, the temperature of the rotary evaporation is 30-60°C, such as 50°C; Step 4: Mix the extracted red flesh apple and cherry plum UHP extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) to prepare a composition, or in step 1, mix the raw materials of red flesh apple and cherry plum according to the aforementioned different ratios, and then extract.
在某些實施方案中,本發明的紅肉蘋果和櫻桃李萃取物藉由超高壓水萃取得到,在某些實施方案中,該超高壓水萃取包括以下步驟: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿,直接獲得果漿,或者用100至300目紗布過濾果汁,製得紅肉蘋果和櫻桃李果汁,分離果汁和果渣;在某些實施方案中,該紗布的目數選取200目; 步驟2:紅肉蘋果和櫻桃李果漿或果渣按料液比1:(2-10)與水混合,超高壓200-600MPa處理3-10min,過濾製得果漿或果渣萃取液;在某些實施方案中,料液比選取1:5;在某些實施方案中,超高壓壓力為400MPa;在某些實施方案中,超高壓處理時間選取5min; 步驟3:紅肉蘋果和櫻桃李果漿萃取液或果汁與果渣萃取液的合併液,在30-60℃旋轉蒸發濃縮,製得紅肉蘋果和櫻桃李超高壓萃取水萃取物;在某些實施方案中,旋轉蒸發溫度選取50℃; 步驟4:將萃取得到的紅肉蘋果和櫻桃李超高壓水萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行萃取。 In certain embodiments, the red-fleshed apple and cherry plum extracts of the present invention are obtained by ultrahigh pressure water extraction, and in certain embodiments, the ultrahigh pressure water extraction comprises the following steps: Step 1: Deseeding or pitting the red-fleshed apples and cherry plums respectively, and beating to obtain pulp directly, or filtering the juices with 100 to 300 mesh gauze to obtain red-flesh apples and cherry plum juices, and separating the juice and pomace; In some embodiments, the mesh number of the gauze is selected as 200 mesh; Step 2: Red meat apple and cherry plum pulp or pomace is mixed with water according to the material-to-liquid ratio of 1: (2-10), treated with ultra-high pressure 200-600MPa for 3-10min, and filtered to obtain pulp or pomace extract; In some embodiments, the material-to-liquid ratio is selected as 1:5; in some embodiments, the ultra-high pressure is 400 MPa; in some embodiments, the ultra-high pressure treatment time is selected for 5 minutes; Step 3: Red flesh apple and cherry plum pulp extract or the combined liquid of juice and pomace extract is concentrated by rotary evaporation at 30-60°C to obtain red flesh apple and cherry plum ultra-high pressure water extract; In some embodiments, the rotary evaporation temperature is selected at 50°C; Step 4: Mix the extracted red flesh apple and cherry plum UHP water extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1 , 10:1) to prepare a composition, or in step 1, mix the raw materials of red flesh apple and cherry plum according to the aforementioned different ratios, and then extract.
在某些實施方案中,本發明的紅肉蘋果和櫻桃李萃取物藉由超高壓醇萃取得到,在某些實施方案中,該超高壓醇萃取包括以下步驟: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿,直接獲得果漿,或者用100至300目紗布過濾果汁,製得紅肉蘋果和櫻桃李果汁,分離果汁和果渣;在某些實施方案中,該紗布的目數選取200目; 步驟2:紅肉蘋果和櫻桃李果漿或果渣按料液比1:(2-10)與50%至95%的乙醇混合,超高壓200-600MPa處理3-10min,過濾製得果漿或果渣萃取液;在某些實施方案中,料液比選取1:5;在某些實施方案中,超高壓壓力為400MPa;在某些實施方案中,超高壓處理時間選取5min;在某些實施方案中,該乙醇為50%的乙醇; 步驟3:紅肉蘋果和櫻桃李果漿萃取液或果汁與果渣萃取液的合併液,在30-60℃旋轉蒸發濃縮,製得紅肉蘋果和櫻桃李超高壓萃取醇萃取物;在某些實施方案中,旋轉蒸發溫度選取50℃;任選地,對萃取物進行揮乾處理以除去其中殘留的乙醇; 步驟4:將萃取得到的紅肉蘋果和櫻桃李超高壓醇萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行萃取。 次臨界萃取(又稱“次臨界萃取”) In certain embodiments, the red-fleshed apple and cherry plum extracts of the present invention are obtained by ultrahigh pressure alcohol extraction. In certain embodiments, the ultrahigh pressure alcohol extraction comprises the following steps: Step 1: Deseeding or pitting the red-fleshed apples and cherry plums respectively, and beating to obtain pulp directly, or filtering the juices with 100 to 300 mesh gauze to obtain red-flesh apples and cherry plum juices, and separating the juice and pomace; In some embodiments, the mesh number of the gauze is selected as 200 mesh; Step 2: Red meat apple and cherry plum pulp or pomace is mixed with 50% to 95% ethanol according to the ratio of material to liquid: (2-10), treated at ultra-high pressure 200-600MPa for 3-10min, and filtered to obtain pulp Or pomace extract; In some embodiments, the solid-liquid ratio is selected as 1:5; In some embodiments, the ultra-high pressure is 400MPa; In some embodiments, the ultra-high pressure treatment time is selected for 5min; In some embodiments, the ethanol is 50% ethanol; Step 3: Red flesh apple and cherry plum pulp extract or the combined solution of fruit juice and pomace extract is concentrated by rotary evaporation at 30-60°C to obtain red flesh apple and cherry plum ultra-high pressure alcohol extract; In some embodiments, the rotary evaporation temperature is selected at 50° C.; optionally, the extract is evaporated to remove residual ethanol therein; Step 4: Mix the extracted red flesh apple and cherry plum UHP alcohol extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1 , 10:1) to prepare a composition, or in step 1, mix the raw materials of red flesh apple and cherry plum according to the aforementioned different ratios, and then extract. Subcritical extraction (aka "subcritical extraction")
在某些實施方案中,紅肉蘋果和櫻桃李萃取物藉由次臨界萃取(例如次臨界水萃取或次臨界醇萃取)得到。In certain embodiments, the red-fleshed apple and cherry plum extracts are obtained by subcritical extraction (eg, subcritical water extraction or subcritical alcohol extraction).
在某些實施方案中,該次臨界萃取包括以下步驟: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿,直接獲得果漿,或者分離出果汁和果渣;在某些實施方案中,利用紗布(例如100至300目紗布,例如200目紗布)過濾分離出果汁和果渣; 步驟2:將果漿或果渣與萃取介質(例如水或乙醇)混合,進行次臨界萃取處理(例如處理10-50min例如30min),過濾得到果漿或果渣萃取液;在某些實施方案中,果漿或果渣與萃取介質以1:(2-10)(例如1:5)的重量比混合;在某些實施方案中,該乙醇為50%至95%的乙醇;在某些實施方案中,次臨界萃取的處理溫度為100-150℃(例如110℃); 步驟3:將果漿或果汁與果渣萃取液的合併液進行濃縮,得到紅肉蘋果和櫻桃李的次臨界萃取物;在某些實施方案中,藉由旋轉蒸發進行濃縮;在某些實施方案中,旋轉蒸發的溫度為30-60℃,例如50℃; 步驟4:將萃取得到的紅肉蘋果和櫻桃李次臨界萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行萃取。 In certain embodiments, the subcritical extraction comprises the steps of: Step 1: Deseeding or pitting red apples and cherry plums, respectively, to obtain pulp directly, or to separate juice and pomace; in some embodiments, using gauze (such as 100 to 300 mesh gauze, such 200 mesh gauze) to filter and separate the juice and pomace; Step 2: Mix the pulp or pomace with an extraction medium (such as water or ethanol), perform subcritical extraction treatment (such as treatment for 10-50min, such as 30min), and filter to obtain pulp or pomace extract; in some embodiments , the pulp or pomace is mixed with the extraction medium in a weight ratio of 1:(2-10), such as 1:5; in certain embodiments, the ethanol is 50% to 95% ethanol; in some In an embodiment, the treatment temperature of the subcritical extraction is 100-150°C (for example, 110°C); Step 3: concentrating the combined pulp or juice and pomace extract to obtain subcritical extracts of red-fleshed apple and cherry plum; in some embodiments, concentrating by rotary evaporation; in some embodiments In the scheme, the temperature of the rotary evaporation is 30-60°C, such as 50°C; Step 4: Mix the extracted red flesh apple and cherry plum subcritical extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) to prepare a composition, or in step 1, mix the raw materials of red flesh apple and cherry plum according to the aforementioned different ratios, and then extract.
在某些實施方案中,本發明的紅肉蘋果和櫻桃李萃取物藉由次臨界水萃取得到,在某些實施方案中,該次臨界水萃取包括以下步驟: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿,直接獲得果漿,或者用100至300目紗布過濾果汁,製得紅肉蘋果和櫻桃李果汁,分離果汁和果渣;在某些實施方案中,該紗布的目數為200目; 步驟2:紅肉蘋果和櫻桃李果漿或果渣按料液比1:(2-10)與水混合,次臨界萃取10-50min,處理溫度為100-150℃,過濾製得果漿或果渣萃取液;在某些實施方案中,料液比選取1:5;在某些實施方案中,處理溫度為110℃;在某些實施方案中,處理時間為30min; 步驟3:紅肉蘋果和櫻桃李果漿萃取液或果汁與果渣萃取液的合併液,在30-60℃旋轉蒸發濃縮,製得紅肉蘋果和櫻桃李次臨界萃取水萃取物;在某些實施方案中,旋轉蒸發溫度選取50℃; 步驟4:將萃取得到的紅肉蘋果和櫻桃李次臨界水萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行萃取。 In certain embodiments, the red-fleshed apple and cherry plum extracts of the present invention are obtained by subcritical water extraction, and in certain embodiments, the subcritical water extraction comprises the steps of: Step 1: Deseeding or pitting the red-fleshed apples and cherry plums respectively, and beating to obtain pulp directly, or filtering the juices with 100 to 300 mesh gauze to obtain red-flesh apples and cherry plum juices, and separating the juice and pomace; In certain embodiments, the gauze has a mesh of 200 mesh; Step 2: Red meat apple and cherry plum pulp or pomace is mixed with water according to the ratio of material to liquid: (2-10), subcritical extraction is carried out for 10-50 minutes, and the treatment temperature is 100-150 ° C, and the pulp or pomace is obtained by filtration Pomace extract; in some embodiments, the ratio of solid to liquid is 1:5; in some embodiments, the treatment temperature is 110°C; in some embodiments, the treatment time is 30min; Step 3: Red flesh apple and cherry plum pulp extract or the combined liquid of juice and pomace extract is concentrated by rotary evaporation at 30-60°C to obtain red flesh apple and cherry plum subcritical water extract; In some embodiments, the rotary evaporation temperature is selected at 50°C; Step 4: Mix the extracted red-flesh apple and cherry plum subcritical water extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1 , 10:1) to prepare a composition, or in step 1, mix the raw materials of red flesh apple and cherry plum according to the aforementioned different ratios, and then extract.
在某些實施方案中,本發明的紅肉蘋果和櫻桃李萃取物藉由次臨界醇萃取得到,在某些實施方案中,該次臨界醇萃取包括以下步驟: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿,直接獲得果漿,或者用100-300目紗布過濾果汁,製得紅肉蘋果和櫻桃李果汁,分離果汁和果渣;在某些實施方案中,該紗布的目數為200目; 步驟2:紅肉蘋果和櫻桃李果漿或果渣按料液比1:(2-10)與50%至95%的乙醇混合,次臨界萃取10-50min,處理溫度為100-150℃,過濾製得果漿或果渣萃取液;在某些實施方案中,料液比選取1:5;在某些實施方案中,處理溫度為110℃;在某些實施方案中,處理時間為30min; 步驟3:紅肉蘋果和櫻桃李果漿萃取液或果汁與果渣萃取液的合併液,在30-60℃旋轉蒸發濃縮,製得紅肉蘋果和櫻桃李次臨界萃取醇萃取物;在某些實施方案中,旋轉蒸發溫度選取50℃;任選地,對萃取物進行揮乾處理以除去其中殘留的乙醇; 步驟4:將萃取得到的紅肉蘋果和櫻桃李次臨界醇萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行萃取。 In certain embodiments, the red-fleshed apple and cherry plum extracts of the present invention are obtained by subcritical alcohol extraction, and in certain embodiments, the subcritical alcohol extraction comprises the steps of: Step 1: Deseeding or pitting the red-fleshed apples and cherry plums, respectively, and beating to obtain pulp directly, or filtering the juices with 100-300 mesh gauze to obtain red-flesh apples and cherry plum juices, and separating the juice and pomace; In certain embodiments, the gauze has a mesh of 200 mesh; Step 2: Red meat apple and cherry plum pulp or pomace is mixed with 50% to 95% ethanol according to the ratio of solid to liquid: (2-10), subcritical extraction for 10-50min, and the treatment temperature is 100-150°C. Filtration to obtain fruit pulp or pomace extract; in some embodiments, the ratio of solid to liquid is 1:5; in some embodiments, the treatment temperature is 110°C; in some embodiments, the treatment time is 30min ; Step 3: Red flesh apple and cherry plum pulp extract or the combined liquid of juice and pomace extract is concentrated by rotary evaporation at 30-60°C to obtain red flesh apple and cherry plum subcritical alcohol extract; In some embodiments, the rotary evaporation temperature is selected at 50° C.; optionally, the extract is evaporated to remove residual ethanol therein; Step 4: Mix the extracted red flesh apple and cherry plum subcritical alcohol extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1 , 10:1) to prepare a composition, or in step 1, mix the raw materials of red flesh apple and cherry plum according to the aforementioned different ratios, and then extract.
如前所述,本發明的組合物的產品形式可以是鮮果、果汁、果醬、果粉(如凍乾粉)、糖果(如壓片糖果)、口服液、膠囊、片劑、果乾、果脯、果酒或糕點。另外,本發明的組合物的產品形式可以是藥品、普通食品或保健食品。在一些實施方案中,果汁、果醬、果粉(如凍乾粉)、糖果(如壓片糖果)、口服液、膠囊、片劑、果乾、果脯、果酒或糕點等產品形式中,本發明的組合物可以作為主要原料,例如,占總原料的30wt%以上、40wt%以上、50wt%以上、60wt%以上、70wt%以上、80wt%以上、90wt%以上或100wt%;任選地,該產品還可以包含例如水、甜味物質等其他成分,或其他種類水果或其萃取物。As mentioned above, the product form of the composition of the present invention can be fresh fruit, fruit juice, jam, fruit powder (such as freeze-dried powder), candy (such as compressed candy), oral liquid, capsule, tablet, dried fruit, preserved fruit, Wine or pastries. In addition, the product form of the composition of the present invention may be medicine, general food or health food. In some embodiments, in product forms such as fruit juice, jam, fruit powder (such as freeze-dried powder), candy (such as compressed candy), oral liquid, capsule, tablet, dried fruit, preserved fruit, fruit wine or cake, the present invention The composition can be used as the main raw material, for example, accounting for more than 30wt%, more than 40wt%, more than 50wt%, more than 60wt%, more than 70wt%, more than 80wt%, more than 90wt% or 100wt% of the total raw materials; optionally, the product It may also contain other ingredients such as water, sweetening substances, or other kinds of fruits or their extracts.
以下提供範例性的製備紅肉蘋果和櫻桃李產品(例如鮮果、果汁、果醬、凍乾粉、壓片糖果、口服液、膠囊)的方法。 鮮果 Exemplary methods for preparing red-fleshed apple and cherry plum products (eg, fresh fruit, juice, jam, freeze-dried powder, compressed candy, oral liquid, capsule) are provided below. fresh fruit
在某些實施方案中,紅肉蘋果和櫻桃李鮮果可以藉由包含以下步驟的方法得到: 步驟1:在成熟前1個月至完全成熟時採收紅肉蘋果和櫻桃李,採果時優先選擇晴天採果; 步驟2:挑選並去除爛果或顏色較差的果; 步驟3:採後冷藏存放; 步驟4:將紅肉蘋果和櫻桃李鮮果按照不同比例(重量比)組合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)。 In certain embodiments, red-fleshed apples and cherry plums can be obtained by a method comprising the steps of: Step 1: Harvest red-fleshed apples and cherry plums from one month before maturity to full maturity, and choose sunny days for fruit picking; Step 2: Pick and remove rotten or poorly colored fruits; Step 3: refrigerated storage after harvest; Step 4: Combine red flesh apples and fresh cherry plums according to different ratios (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1).
獲得的紅肉蘋果和櫻桃李鮮果可供直接食用。 果汁 The obtained fresh apples with red flesh and cherry plums can be eaten directly. juice
在某些實施方案中,紅肉蘋果和櫻桃李果汁可以藉由包含以下步驟的方法得到: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿; 步驟2:對漿料進行過濾(例如用100至300目紗布過濾),製得紅肉蘋果和櫻桃李果汁濁汁;在某些實施方案中,該紗布的目數為200目; 步驟3:將紅肉蘋果和櫻桃李濁汁按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備果汁。 In certain embodiments, red apple and cherry plum juices may be obtained by a process comprising the steps of: Step 1: Deseeding or pitting the red flesh apples and cherry plums respectively, and beating; Step 2: Filtrating the slurry (for example, filtering with gauze of 100 to 300 mesh) to obtain turbid fruit juice of red apple and cherry plum juice; in some embodiments, the mesh of the gauze is 200 mesh; Step 3: Mix red flesh apple and cherry plum juice in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) to prepare Composition, or in step 1 first mix the raw materials of red flesh apple and cherry plum according to the above-mentioned different ratios, and then make pulp to prepare fruit juice.
在某些實施方案中,紅肉蘋果和櫻桃李果汁還可以藉由包含以下步驟的方法得到: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿; 步驟2:對漿料進行過濾(例如用100至300目紗布過濾),加果膠酶酶解過濾;製得紅肉蘋果和櫻桃李果汁清汁;在某些實施方案中,該紗布的目數為200目; 步驟3:將紅肉蘋果和櫻桃李清汁按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備果汁。 果醬 In some embodiments, red apple and cherry plum juices can also be obtained by a process comprising the steps of: Step 1: Deseeding or pitting the red flesh apples and cherry plums respectively, and beating; Step 2: filter the slurry (for example, filter with 100 to 300 mesh gauze), add pectinase to enzymatically filter; make red apple and cherry plum juice clear juice; in some embodiments, the mesh of the gauze 200 mesh; Step 3: Mix red flesh apple and cherry plum juice in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) to prepare Composition, or in step 1, firstly mix the raw materials of red flesh apple and cherry plum according to the aforementioned different ratios, and then perform beating to prepare fruit juice. jam
在某些實施方案中,紅肉蘋果和櫻桃李果醬可以藉由包含以下步驟的方法得到: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿; 步驟2:將果漿水煮加熱濃縮製成紅肉蘋果和櫻桃李果醬; 步驟3:將紅肉蘋果和櫻桃李果醬按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備果醬。 凍乾粉 In certain embodiments, red apple and marmalade are obtainable by a method comprising the steps of: Step 1: Deseeding or pitting the red flesh apples and cherry plums respectively, and beating; Step 2: Boil and heat the pulp to make red apple and cherry plum jam; Step 3: Mix red apple and cherry plum jam in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) to prepare Composition, or in step 1 first mix the raw materials of red apples and cherry plums according to the aforementioned different ratios, and then beat to prepare jam. freeze-dried powder
在某些實施方案中,紅肉蘋果和櫻桃李凍乾粉可以藉由包含以下步驟的方法得到: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿, 步驟2:將果漿冷凍乾燥製成果漿凍乾粉; 步驟3:將紅肉蘋果和櫻桃李凍乾粉按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備凍乾粉。 In some embodiments, the freeze-dried powder of red-fleshed apple and cherry plum can be obtained by a method comprising the following steps: Step 1: Remove the seeds or pits of the red flesh apples and cherry plums respectively, and beat Step 2: Freeze-drying the pulp to make a freeze-dried pulp powder; Step 3: Mix red flesh apple and cherry plum freeze-dried powder according to different ratios (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) It is prepared into a composition, or in step 1, the raw materials of red-fleshed apples and cherry plums are mixed according to the aforementioned different ratios, and then beaten to prepare freeze-dried powder.
在某些實施方案中,紅肉蘋果和櫻桃李凍乾粉還可以藉由包含以下步驟的方法得到: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿; 步驟2:對漿料進行過濾(例如用100至300目紗布過濾),製得紅肉蘋果和櫻桃李果汁;在某些實施方案中,該紗布的目數為200目; 步驟3:將果汁冷凍乾燥製成果汁凍乾粉; 步驟4:將紅肉蘋果和櫻桃李凍乾粉按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備凍乾粉。 壓片糖果 In some embodiments, the freeze-dried powder of red-flesh apple and cherry plum can also be obtained by a method comprising the following steps: Step 1: Deseeding or pitting the red flesh apples and cherry plums respectively, and beating; Step 2: filtering the slurry (for example, filtering with 100 to 300 mesh gauze) to obtain red flesh apple and cherry plum juice; in some embodiments, the gauze has a mesh of 200 mesh; Step 3: freeze-drying the fruit juice to make fruit juice freeze-dried powder; Step 4: Mix red flesh apple and cherry plum freeze-dried powder according to different ratios (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) It is prepared into a composition, or in step 1, the raw materials of red-fleshed apples and cherry plums are mixed according to the aforementioned different ratios, and then beaten to prepare freeze-dried powder. Tablet Candy
在某些實施方案中,紅肉蘋果和櫻桃李壓片糖果可以藉由包含以下步驟的方法得到: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿; 步驟2:將果漿冷凍乾燥製成果漿凍乾粉; 步驟3:對果漿凍乾粉和輔料進行壓片製成壓片糖果; 步驟4:將紅肉蘋果和櫻桃李壓片糖果按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備壓片糖果。 In certain embodiments, red apple and cherry plum candies are obtainable by a method comprising the steps of: Step 1: Deseeding or pitting the red flesh apples and cherry plums respectively, and beating; Step 2: Freeze-drying the pulp to make a freeze-dried pulp powder; Step 3: tableting the freeze-dried fruit pulp and auxiliary materials to make tablet candy; Step 4: Mix red apples and cherry plum candies in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) It is prepared into a composition, or in step 1, the raw materials of red-fleshed apples and cherry plums are first mixed according to the aforementioned different ratios, and then beating is performed to prepare tableted candies.
在某些實施方案中,紅肉蘋果和櫻桃李壓片糖果還可以藉由包含以下步驟的方法得到: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿; 步驟2:對漿料進行過濾(例如用100至300目紗布過濾),製得紅肉蘋果果汁;在某些實施方案中,該紗布的目數為200目; 步驟3:將果汁冷凍乾燥製成果汁凍乾粉; 步驟4:對果汁凍乾粉和輔料進行壓片製成壓片糖果。 步驟5:將紅肉蘋果和櫻桃李壓片糖果按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備壓片糖果。 口服液 In some embodiments, red apple and cherry plum candies are also obtainable by a process comprising the steps of: Step 1: Deseeding or pitting the red flesh apples and cherry plums respectively, and beating; Step 2: filtering the slurry (for example, filtering with gauze of 100 to 300 mesh) to obtain apple juice with red flesh; in some embodiments, the mesh of the gauze is 200 mesh; Step 3: freeze-drying the fruit juice to make fruit juice freeze-dried powder; Step 4: Tablet the freeze-dried fruit juice powder and auxiliary materials to make tablet candy. Step 5: Mix red apples and cherry plum candies in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) It is prepared into a composition, or in step 1, the raw materials of red-fleshed apples and cherry plums are first mixed according to the aforementioned different ratios, and then beating is performed to prepare tableted candies. oral liquid
在某些實施方案中,紅肉蘋果和櫻桃李口服液可以藉由包含以下步驟的方法得到: 步驟1:製備不同比例(重量比)(1:10、1:5、1:2、1:1、2:1、5:1、10:1)的紅肉蘋果和櫻桃李萃取物(例如,藉由浸提萃取、酶解超音波萃取、超高壓萃取或次臨界萃取製得,步驟同上文); 步驟2:對紅肉蘋果和櫻桃李萃取物進行滅菌製得紅肉蘋果口服液。 In some embodiments, the red-fleshed apple and cherry plum oral liquid can be obtained by a method comprising the following steps: Step 1: Prepare red-fleshed apple and cherry plum extracts (e.g. , prepared by leaching extraction, enzymatic ultrasonic extraction, ultra-high pressure extraction or subcritical extraction, the steps are the same as above); Step 2: Sterilize the red-flesh apple and cherry plum extracts to prepare the red-flesh apple oral liquid.
在某些實施方案中,紅肉蘋果和櫻桃李口服液還可以藉由包含以下步驟的方法得到: 步驟1:製備不同比例(重量比)(1:10、1:5、1:2、1:1、2:1、5:1、10:1)的紅肉蘋果和櫻桃李萃取物(例如,藉由浸提萃取、酶解超音波萃取、超高壓萃取或次臨界萃取製得,步驟同上文); 步驟2:加果膠酶酶解過濾製備清汁萃取物組合物; 步驟3:對紅肉蘋果和櫻桃李清汁萃取物進行滅菌製得紅肉蘋果口服液。 膠囊 In some embodiments, the red-flesh apple and cherry plum oral liquid can also be obtained by a method comprising the following steps: Step 1: Prepare red-fleshed apple and cherry plum extracts (e.g. , prepared by leaching extraction, enzymatic ultrasonic extraction, ultra-high pressure extraction or subcritical extraction, the steps are the same as above); Step 2: adding pectinase to enzymatically hydrolyze and filter to prepare clear juice extract composition; Step 3: Sterilize the extracts of red-flesh apple and cherry plum juice to prepare red-flesh apple oral liquid. capsule
在某些實施方案中,紅肉蘋果和櫻桃李膠囊可以藉由包含以下步驟的方法得到: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿; 步驟2:將果漿冷凍乾燥製成果漿凍乾粉; 步驟3:將紅肉蘋果和櫻桃李凍乾粉按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備凍乾粉; 步驟4:將果漿凍乾粉裝入膠囊殼,製成膠囊。 In certain embodiments, red-fleshed apple and cherry plum capsules are obtainable by a method comprising the steps of: Step 1: Deseeding or pitting the red flesh apples and cherry plums respectively, and beating; Step 2: Freeze-drying the pulp to make a freeze-dried pulp powder; Step 3: Mix red flesh apple and cherry plum freeze-dried powder according to different ratios (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) Prepare a composition, or mix the raw materials of red-fleshed apples and cherry plums according to the aforementioned different ratios in step 1, and then perform beating to prepare freeze-dried powder; Step 4: Put the freeze-dried fruit pulp powder into the capsule shell to make a capsule.
在某些實施方案中,紅肉蘋果和櫻桃李膠囊還可以藉由包含以下步驟的方法得到: 步驟1:分別將紅肉蘋果和櫻桃李去籽或去核後打漿; 步驟2:對漿料進行過濾(例如用100至300目紗布過濾),製得紅肉蘋果和櫻桃李果汁;在某些實施方案中,該紗布的目數為200目; 步驟3:將果汁冷凍乾燥製成果汁凍乾粉; 步驟4:將紅肉蘋果和櫻桃李凍乾粉按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者在步驟1先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備凍乾粉; 步驟5:將果汁凍乾粉裝入膠囊殼,製成膠囊。 有益效果 In some embodiments, red flesh apple and cherry plum capsules can also be obtained by a method comprising the following steps: Step 1: Deseeding or pitting the red flesh apples and cherry plums respectively, and beating; Step 2: filtering the slurry (for example, filtering with 100 to 300 mesh gauze) to obtain red flesh apple and cherry plum juice; in some embodiments, the gauze has a mesh of 200 mesh; Step 3: freeze-drying the fruit juice to make fruit juice freeze-dried powder; Step 4: Mix red flesh apple and cherry plum freeze-dried powder according to different ratios (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) Prepare a composition, or mix the raw materials of red-fleshed apples and cherry plums according to the aforementioned different ratios in step 1, and then perform beating to prepare freeze-dried powder; Step 5: The fruit juice freeze-dried powder is packed into a capsule shell to make a capsule. Beneficial effect
本發明選用天然紅肉蘋果和櫻桃李,製備的紅肉蘋果和櫻桃李組合產品具有很好的降血糖作用,兩種複配的效果優於單獨使用紅肉蘋果或櫻桃李,具有協同增效作用。組合物與藥物聯用的效果優於組合物或藥物單獨使用的效果。The present invention selects natural red-flesh apples and cherry plums, and the prepared combination product of red-flesh apples and cherry plums has a good hypoglycemic effect. effect. The effect of the combined use of the composition and the medicine is better than that of the composition or the medicine alone.
下面將結合實施例對本發明的實施方案進行詳細描述,但是本領域技術人員將會理解,下列實施例僅用於說明本發明,而不應視為限定本發明的範圍。 實施例1: Embodiments of the present invention will be described in detail below in conjunction with examples, but those skilled in the art will understand that the following examples are only used to illustrate the present invention, and should not be considered as limiting the scope of the present invention. Example 1:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果和櫻桃李鮮果。The red-flesh apple and cherry plum products described in this embodiment refer to red-flesh apple and cherry plum fresh fruit.
紅肉蘋果(洪勳1號)和櫻桃李(黑果)在成熟前1個月至完全成熟時採收,採果時優先選擇晴天採果,挑選並去除爛果或顏色較差的果,採後冷藏存放。獲得的紅肉蘋果和櫻桃李按照不同比例(重量比)組合(1:10、1:5、1:2、1:1、2:1、5:1、10:1),鮮果可供直接食用。 實施例2: Red-fleshed apples (Hongxun No. 1) and cherry plums (black fruit) are harvested from one month before maturity to full maturity. When picking fruits, it is preferred to pick fruits on sunny days, select and remove rotten or poor-colored fruits, and harvest them. Then store in the refrigerator. The obtained red flesh apples and cherry plums are combined according to different ratios (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1), and the fresh fruits can be used directly edible. Example 2:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果和櫻桃李果汁濁汁。The red-fleshed apple and cherry plum products described in this embodiment refer to red-flesh apple and cherry plum juice cloudy juice.
紅肉蘋果(洪勳1號)和櫻桃李(黑果)採收後去籽或去核後打漿,用200目紗布過濾果汁,製得紅肉蘋果和櫻桃李果汁濁汁。將紅肉蘋果和櫻桃李濁汁按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備果汁。 實施例3: Red-fleshed apples (Hongxun No. 1) and cherry plums (black fruit) were harvested and then pulped after deseeding or pitting. The juice was filtered with 200-mesh gauze to obtain turbid juice from red-fleshed apples and cherry plums. Red meat apple and cherry plum cloudy juice are mixed according to different ratios (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) to prepare a composition , or first mix the raw materials of red apples and cherry plums according to the aforementioned different ratios, and then beat to prepare juice. Example 3:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果和櫻桃李果汁清汁。The red-flesh apple and cherry plum products described in this embodiment refer to the clear juice of red-flesh apple and cherry plum juice.
紅肉蘋果(洪勳1號)和櫻桃李(黑果)採收後去籽或去核後打漿,用200目紗布過濾果汁,製得紅肉蘋果和櫻桃李果汁濁汁。加果膠酶酶解過濾得清汁。將紅肉蘋果和櫻桃李清汁按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備果汁。 實施例4: Red-fleshed apples (Hongxun No. 1) and cherry plums (black fruit) were harvested and then pulped after deseeding or pitting. The juice was filtered with 200-mesh gauze to obtain turbid juice from red-fleshed apples and cherry plums. Add pectinase to hydrolyze and filter to obtain clear juice. The composition is prepared by mixing red-fleshed apples and cherry-plum juice in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1), Or firstly mix red meat apples and cherry plum raw materials according to the above-mentioned different ratios, and then make a beating to prepare fruit juice. Example 4:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果和櫻桃李果醬。The red-flesh apple and cherry plum products described in this embodiment refer to red-flesh apple and cherry plum jam.
紅肉蘋果(洪勳1號)和櫻桃李(黑果)去籽或去核後打漿,水煮加熱製成較稠的果醬。將紅肉蘋果和櫻桃李果醬按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備果醬。 實施例5: Red-fleshed apples (Hong Xun No. 1) and cherry plums (black fruit) are deseeded or pitted, then pulped, boiled and heated to make a thicker jam. Red flesh apple and cherry plum jam are mixed according to different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) to prepare a composition, Or mix the raw materials of red-fleshed apples and cherry plums according to the above-mentioned different ratios, and then make a beating to prepare jam. Example 5:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果和櫻桃李凍乾粉。The red-fleshed apple and cherry plum products described in this embodiment refer to the freeze-dried powder of red-flesh apple and cherry plum.
紅肉蘋果(洪勳1號)和櫻桃李(黑果)去籽或去核後打漿,冷凍乾燥製成果漿凍乾粉。將紅肉蘋果和櫻桃李凍乾粉按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備凍乾粉。 實施例6: Red-fleshed apples (Hongxun No. 1) and cherry plums (Heiguo) were pulped after deseeding or pitting, and freeze-dried to make pulp freeze-dried powder. Mix red flesh apple and cherry plum freeze-dried powder according to different ratios (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) to prepare a combination or mix the raw materials of red-fleshed apples and cherry plums according to the above-mentioned different ratios, and then perform beating to prepare freeze-dried powder. Embodiment 6:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果和櫻桃李壓片糖果。The red-flesh apple and cherry plum products described in this embodiment refer to red-flesh apple and cherry plum sliced candies.
紅肉蘋果(洪勳1號)和櫻桃李(黑果)去籽或去核後打漿,冷凍乾燥製成果漿凍乾粉,對果漿凍乾粉和輔料進行壓片製成壓片糖果。將紅肉蘋果和櫻桃李壓片糖果按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物,或者先按前述不同比例混合紅肉蘋果和櫻桃李原料,再進行打漿製備壓片糖果。 實施例7: Red-fleshed apples (Hong Xun No. 1) and cherry plums (black fruit) are deseeded or pitted, then pulped, freeze-dried to make pulp freeze-dried powder, and the pulp freeze-dried powder and auxiliary materials are compressed to make tablet candy. Mix red apples and cherry plum candies in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10:1) to prepare a combination or mix the raw materials of red flesh apple and cherry plum according to the aforementioned different proportions, and then beat the pulp to prepare tablet candy. Embodiment 7:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果和櫻桃李水浸提萃取口服液。 (1) 紅肉蘋果(洪勳1號)和櫻桃李(黑果)去籽或去核後打漿,製得紅肉蘋果和櫻桃李果漿。 (2) 紅肉蘋果和櫻桃李果漿按料液比1:5加水,50℃水浸提萃取60min,過濾製得果漿萃取液。 (3) 萃取液在50℃旋轉蒸發濃縮,製得紅肉蘋果和櫻桃李水浸提萃取物。 (4) 將萃取得到的紅肉蘋果和櫻桃李萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物。 (5) 對紅肉蘋果和櫻桃李組合萃取物進行滅菌製得口服液。 實施例8: The red-flesh apple and cherry plum products described in this embodiment refer to the oral liquid of red-flesh apple and cherry plum water extraction. (1) Red-fleshed apples (Hongxun No. 1) and cherry plums (black fruit) were deseeded or pitted and then pulped to obtain red-flesh apple and cherry plum pulp. (2) Add water to the pulp of red-fleshed apples and cherry plums according to the ratio of solid to liquid 1:5, extract with water at 50°C for 60 minutes, and filter to obtain the pulp extract. (3) The extract was concentrated by rotary evaporation at 50°C to obtain water extracts of red flesh apple and cherry plum. (4) Mix the extracted red flesh apple and cherry plum extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10: 1) Prepared into a composition. (5) The oral liquid was prepared by sterilizing the combined extracts of red-flesh apple and cherry plum. Embodiment 8:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果(紅色之愛)和櫻桃李(紅果)水浸提萃取口服液。製備步驟同實施例7。 實施例9: The red-flesh apple and cherry plum products described in this example refer to red-flesh apple (red love) and cherry plum (red fruit) water extraction oral liquid. The preparation steps are the same as in Example 7. Embodiment 9:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果(洪勳1號)和櫻桃李(黑果)醇浸提萃取口服液。The red-flesh apple and cherry plum products described in this example refer to the oral liquid of red-flesh apple (Hongxun No. 1) and cherry plum (black fruit) alcohol extraction.
參照實施例7的(1)至(5)步驟處理,其中果漿按料液比1:5加50%乙醇。醇萃取物進行揮乾乙醇處理。 實施例10: Refer to the steps (1) to (5) of Example 7, wherein the fruit pulp is added with 50% ethanol at a ratio of 1:5 to material. The alcoholic extract was evaporated to dryness with ethanol. Example 10:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果和櫻桃李酶解超音波水萃取口服液。 (1) 紅肉蘋果(洪勳1號)和櫻桃李(黑果)去籽或去核後打漿,製得紅肉蘋果和櫻桃李果漿。 (2) 紅肉蘋果和櫻桃李果漿按料液比1:5加水,添加0.5%(以果漿重量為基準)的纖維素酶,45℃水浴萃取60min,500W超音波30min,過濾製得果漿萃取液。 (3) 萃取液在50℃旋轉蒸發濃縮,製得紅肉蘋果和櫻桃李酶解超音波水萃取物。 (4) 將萃取得到的紅肉蘋果和櫻桃李萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物。 (5) 對紅肉蘋果和櫻桃李組合萃取物進行滅菌製得口服液。 實施例11: The red-flesh apple and cherry plum products described in this embodiment refer to the oral liquid of red-flesh apple and cherry plum enzymatically hydrolyzed with ultrasonic water extraction. (1) Red-fleshed apples (Hongxun No. 1) and cherry plums (black fruit) were deseeded or pitted and then pulped to obtain red-flesh apple and cherry plum pulp. (2) Red flesh apple and cherry plum pulp are prepared by adding water at a material-to-liquid ratio of 1:5, adding 0.5% (based on the weight of the pulp) cellulase, extracting in a water bath at 45°C for 60 minutes, ultrasonic wave at 500W for 30 minutes, and filtering. Fruit pulp extract. (3) The extract was concentrated by rotary evaporation at 50°C to obtain enzymolysis ultrasonic water extracts of red flesh apple and cherry plum. (4) Mix the extracted red flesh apple and cherry plum extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10: 1) Prepared into a composition. (5) The oral liquid was prepared by sterilizing the combined extracts of red-flesh apple and cherry plum. Example 11:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果(洪勳3號)和櫻桃李(紅果)酶解超音波水萃取口服液。製備步驟同實施例10。 實施例12: The red-flesh apple and cherry plum products described in this example refer to red-flesh apple (Hongxun No. 3) and cherry plum (red fruit) enzymatically hydrolyzed ultrasonic water extraction oral liquid. The preparation steps are the same as in Example 10. Example 12:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果(洪勳1號)和櫻桃李(黑果)酶解超音波醇萃取口服液。The red-flesh apple and cherry plum products described in this example refer to the oral liquid of red-flesh apple (Hongxun No. 1) and cherry plum (black fruit) enzymolysis ultrasonic alcohol extraction.
參照實施例10的(1)至(5)步驟處理,其中果漿按料液比1:5加50%。醇萃取物進行揮乾乙醇處理。 實施例13: Refer to the steps (1) to (5) of Example 10, wherein the pulp is added 50% according to the ratio of material to liquid: 1:5. The alcoholic extract was evaporated to dryness with ethanol. Example 13:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果和櫻桃李超高壓水萃取口服液。 (1) 紅肉蘋果(洪勳1號)和櫻桃李(黑果)去籽或去核後打漿,製得紅肉蘋果和櫻桃李果漿。 (2) 紅肉蘋果和櫻桃李果漿按料液比1:5加水,超高壓400Mpa處理5min,過濾製得果漿萃取液。 (3) 萃取液在50℃旋轉蒸發濃縮,製得紅肉蘋果和櫻桃李超高壓水萃取物。 (4) 將萃取得到的紅肉蘋果和櫻桃李萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物。 (5) 對紅肉蘋果和櫻桃李組合萃取物進行滅菌製得口服液。 實施例14: The red-fleshed apple and cherry plum products described in this embodiment refer to the ultra-high pressure water extraction oral liquid of red-flesh apple and cherry plum. (1) Red-fleshed apples (Hongxun No. 1) and cherry plums (black fruit) were deseeded or pitted and then pulped to obtain red-flesh apple and cherry plum pulp. (2) Add water to the pulp of red-fleshed apples and cherry plums at a material-to-liquid ratio of 1:5, process at an ultra-high pressure of 400Mpa for 5 minutes, and filter to obtain pulp extracts. (3) The extract was concentrated by rotary evaporation at 50°C to obtain ultra-high pressure water extracts of red flesh apple and cherry plum. (4) Mix the extracted red flesh apple and cherry plum extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10: 1) Prepared into a composition. (5) The oral liquid was prepared by sterilizing the combined extracts of red-flesh apple and cherry plum. Example 14:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果(洪勳6號)和櫻桃李(紅果)超高壓水萃取口服液。製備步驟同實施例13。 實施例15: The red-fleshed apple and cherry plum products described in this example refer to red-flesh apple (Hong Xun No. 6) and cherry plum (red fruit) ultra-high pressure water extraction oral liquid. The preparation steps are the same as in Example 13. Example 15:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果(洪勳1號)和櫻桃李(黑果)超高壓醇萃取口服液。The red-flesh apple and cherry plum products described in this example refer to the ultra-high pressure alcohol extraction oral liquid of red-flesh apple (Hongxun No. 1) and cherry plum (black fruit).
參照實施例13的(1)至(5)步驟處理,其中果漿按料液比1:5加50%。醇萃取物進行揮乾乙醇處理。 實施例16: Refer to the steps (1) to (5) of Example 13, in which the pulp is added 50% according to the ratio of material to liquid: 1:5. The alcoholic extract was evaporated to dryness with ethanol. Example 16:
本實施例所述的紅肉蘋果和櫻桃李產品指紅肉蘋果和櫻桃李次臨界水萃取口服液。 (1) 紅肉蘋果(洪勳1號)和櫻桃李(黑果)去籽或去核後打漿,製得紅肉蘋果和櫻桃李果漿。 (2) 紅肉蘋果和櫻桃李果漿按料液比1:5加水,次臨界萃取30min,處理溫度為110℃,過濾製得果漿萃取液。 (3) 萃取液在50℃旋轉蒸發濃縮,製得紅肉蘋果和櫻桃李次臨界水萃取物。 (4) 將萃取得到的紅肉蘋果和櫻桃李萃取物按照不同比例(重量比)混合(1:10、1:5、1:2、1:1、2:1、5:1、10:1)製備成組合物。 (5) 對紅肉蘋果和櫻桃李組合萃取物進行滅菌製得口服液。 實施例產品的降血糖效果評價: 實驗例1:斑馬魚降血糖效果評價 (1)試驗方法 The red-fleshed apple and cherry plum products described in this embodiment refer to the subcritical water extraction oral liquid of red-flesh apple and cherry plum. (1) Red-fleshed apples (Hongxun No. 1) and cherry plums (black fruit) were deseeded or pitted and then pulped to obtain red-flesh apple and cherry plum pulp. (2) Red flesh apple and cherry plum pulp were added with water according to the ratio of solid to liquid 1:5, subcritical extraction was carried out for 30 minutes, the treatment temperature was 110°C, and the pulp extract was obtained by filtration. (3) The extract was concentrated by rotary evaporation at 50°C to obtain subcritical water extracts of red-fleshed apple and cherry plum. (4) Mix the extracted red flesh apple and cherry plum extracts in different proportions (weight ratio) (1:10, 1:5, 1:2, 1:1, 2:1, 5:1, 10: 1) Prepared into a composition. (5) The oral liquid was prepared by sterilizing the combined extracts of red-flesh apple and cherry plum. The hypoglycemic effect evaluation of embodiment product: Experimental example 1: Evaluation of the hypoglycemic effect of zebrafish (1) Test method
選取胚胎發育時相為5dpf的斑馬魚幼魚,分為模型組、對照組、陽性藥組(二甲雙胍)和樣品組。模型組、陽性藥組和樣品組用葡萄糖溶液浸泡處理,並喂以高脂飼料;對照組,用系統水養殖,並飼喂高脂飼料。每天餵食幼魚2次。陽性藥物組給予二甲雙胍,樣品組給予待測樣品。在9dpf時,收集幼魚,研磨後加水,用血糖儀測量總組織液中的葡萄糖含量。 血糖抑製率(%)=(模型組血糖-藥物組血糖)/模型組血糖×100 (2)試驗結果 Zebrafish juveniles with an embryonic development phase of 5 dpf were selected and divided into model group, control group, positive drug group (metformin) and sample group. The model group, the positive drug group and the sample group were soaked in glucose solution and fed with high-fat feed; the control group was cultured with system water and fed with high-fat feed. Feed the juveniles 2 times a day. The positive drug group was given metformin, and the sample group was given the test sample. At 9dpf, collect juvenile fish, add water after grinding, and measure the glucose content in the total interstitial fluid with a blood glucose meter. Blood sugar suppression rate (%) = (model group blood sugar - drug group blood sugar) / model group blood sugar × 100 (2) Test results
試驗結果如下表1所示。下表1中,單獨紅肉蘋果組和單獨櫻桃李組的樣品分別為實施例10步驟(3)製得的紅肉蘋果酶解超音波水萃取物和櫻桃李酶解超音波水萃取物。紅肉蘋果和櫻桃李組合物組的樣品為實施例10步驟(4)製得的各重量比的組合物。另外,各組對應的給予濃度用單底線示出,其中:1mg/mL或0.5mg/mL表示陽性藥分散在水中的濃度;0.01%表示紅肉蘋果酶解超音波水萃取物、或者櫻桃李酶解超音波水萃取物、或者不同重量比的由紅肉蘋果酶解超音波水萃取物和櫻桃李酶解超音波水萃取物組成的組合物分散在水中的濃度。The test results are shown in Table 1 below. In Table 1 below, the samples of the red-flesh apple group and the cherry plum group are the red-flesh apple enzymatically hydrolyzed ultrasonic water extract and cherry plum enzymatically hydrolyzed ultrasonic water extract prepared in step (3) of Example 10, respectively. The samples of the composition group of red-flesh apple and cherry plum are compositions of various weight ratios prepared in step (4) of Example 10. In addition, the administration concentration corresponding to each group is shown by a single bottom line, in which: 1mg/mL or 0.5mg/mL represents the concentration of the active drug dispersed in water; 0.01% represents the enzymatic hydrolysis ultrasonic water extract of red meat apple, or cherry plum Concentration of enzymatic hydrolysis ultrasonic water extract, or composition composed of red flesh apple enzymatic hydrolysis ultrasonic water extract and cherry plum enzymatic ultrasonic water extract in different weight ratios dispersed in water.
之後,參照《CN104127427B一種抗癌增效組合物》和文獻《薑黃素與阿黴素聯合應用抗腫瘤的協同作用》,計算相互作用係數q=E(A+B)/(EA+(1-EA)×EB)。其中E( A + B) 為兩藥合用的抑製率,EA和EB分別為兩藥單用的抑製率。q為0.85至1.15表示作用相加,q>1.15表示作用增強,有協同作用,q < 0. 85 表示兩藥作用拮抗。計算結果如下表1所示。
表1 紅肉蘋果和櫻桃李組合物(實施例10)斑馬魚降血糖效果
由上表1可知,紅肉蘋果和櫻桃李組合物(10:1至1:10)的血糖抑製率高於單獨使用時的數值,計算q值均大於1.15,說明具有協同增效作用。It can be seen from the above table 1 that the blood sugar suppression rate of the combination of red flesh apple and cherry plum (10:1 to 1:10) is higher than that when used alone, and the calculated q values are all greater than 1.15, indicating that it has a synergistic effect.
另外,紅肉蘋果和櫻桃李組合物與陽性藥複配使用時具有相加的作用(0.85<q<1.15)。組合物與陽性藥的複配降血糖效果優於單獨使用時的效果。與較低劑量的陽性藥複配使用能較顯著地提升效果。 實驗例2:小鼠降血糖效果評價 (1)試驗方法 In addition, the composition of red-flesh apple and cherry plum has an additive effect (0.85<q<1.15) when used in combination with the active drug. The hypoglycemic effect of the combination of the composition and the active drug is better than that of the single use. Combined use with lower doses of active drugs can significantly improve the effect. Experimental example 2: Evaluation of hypoglycemic effect in mice (1) Test method
取健康db/db小鼠,分為陽性藥組(二甲雙胍、達格列淨)、模型組以及樣品組;另外還設有正常對照組,正常對照組為BKS背景的C57野生型小鼠;每組20隻。在適應性飼養後,模型組給予蒸餾水(0.5mL/隻),陽性藥組給予二甲雙胍或達格列淨,樣品組給予樣品(0.5mL/隻),實驗週期為14天。尾尖取血後用血糖儀測量小鼠血液中的葡萄糖含量。 血糖抑製率(%)=(模型組血糖值-藥物組血糖值)/模型組血糖值×100 (2)試驗結果 Healthy db/db mice were taken and divided into positive drug group (metformin, dapagliflozin), model group and sample group; in addition, there was a normal control group, which was C57 wild-type mice with BKS background; Group 20. After adaptive feeding, the model group was given distilled water (0.5mL/rat), the positive drug group was given metformin or dapagliflozin, and the sample group was given samples (0.5mL/rat), and the experimental period was 14 days. After blood was taken from the tip of the tail, the glucose content in the mouse blood was measured with a blood glucose meter. Blood sugar suppression rate (%) = (blood sugar value of model group - blood sugar value of drug group) / blood sugar value of model group × 100 (2) Test results
試驗結果如下表2所示。下表2中,單獨紅肉蘋果組和單獨櫻桃李組的樣品分別為實施例10步驟(3)製得的紅肉蘋果酶解超音波水萃取物和櫻桃李酶解超音波水萃取物。紅肉蘋果和櫻桃李組合物組的樣品為實施例10步驟(4)製得的各重量比的組合物。另外,各組對應的給予劑量用單底線示出。The test results are shown in Table 2 below. In Table 2 below, the samples of the red-flesh apple group and the cherry plum group are the red-flesh apple enzymatically hydrolyzed ultrasonic water extract and cherry plum enzymatically hydrolyzed ultrasonic water extract prepared in step (3) of Example 10, respectively. The samples of the composition group of red-flesh apple and cherry plum are compositions of various weight ratios prepared in step (4) of Example 10. In addition, the corresponding administered doses for each group are shown with a single bottom line.
之後,參照《CN104127427B一種抗癌增效組合物》和文獻《薑黃素與阿黴素聯合應用抗腫瘤的協同作用》,計算相互作用係數q=E(A+B)/(EA+(1-EA)×EB)。其中E( A + B) 為兩藥合用的抑製率,EA和EB分別為兩藥單用的抑製率。q為0.85至1.15表示作用相加,q>1.15表示作用增強,有協同作用,q < 0. 85 表示兩藥作用拮抗。計算結果如下表2所示。
表2 紅肉蘋果和櫻桃李組合物(實施例10)小鼠降血糖效果
由上表2可知,紅肉蘋果和櫻桃李組合物(10:1至1:10)的血糖抑製率高於單獨使用時的數值,計算q值均大於1.15,說明具有協同增效作用。另外,紅肉蘋果和櫻桃李組合物與陽性藥複配使用時具有相加的作用(0.85<q<1.15)。It can be seen from the above table 2 that the blood sugar suppression rate of the combination of red flesh apple and cherry plum (10:1 to 1:10) is higher than that when used alone, and the calculated q values are all greater than 1.15, indicating that it has a synergistic effect. In addition, the composition of red-flesh apple and cherry plum has an additive effect (0.85<q<1.15) when used in combination with the active drug.
以上實施例僅用以說明本發明的技術方案而非限制,對本發明的技術方案進行修改或者等同替換,而不脫離本發明技術方案的宗旨和範圍的,其均應涵蓋在本發明的保護範圍之內。The above examples are only used to illustrate the technical solution of the present invention rather than limit it. Any modification or equivalent replacement of the technical solution of the present invention without departing from the purpose and scope of the technical solution of the present invention shall be covered by the protection scope of the present invention within.
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011347439.3 | 2020-11-26 | ||
CN202011347439.3A CN114532466B (en) | 2020-11-26 | 2020-11-26 | Red apple and cherry plum composition and application thereof in reducing blood sugar |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202228753A TW202228753A (en) | 2022-08-01 |
TWI802101B true TWI802101B (en) | 2023-05-11 |
Family
ID=81659101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW110143996A TWI802101B (en) | 2020-11-26 | 2021-11-25 | Compositions of red-fleshed apples and cherry plums and their use in lowering blood sugar |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN114532466B (en) |
TW (1) | TWI802101B (en) |
WO (1) | WO2022111570A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023217115A1 (en) * | 2022-05-13 | 2023-11-16 | 浙江养生堂天然药物研究所有限公司 | Composition of malus niedzwetzkyana dieck and prunus cerasifera ehrhart and use thereof in terms of resisting atherosclerosis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102266388B (en) * | 2011-07-20 | 2014-08-27 | 天津市聚星康华医药科技有限公司 | Pharmaceutical composition for preventing and treating type 2 diabetes and complication thereof |
CN106805042A (en) * | 2017-02-13 | 2017-06-09 | 临沂大学 | A kind of grape apple beverage of reducing blood lipid and preparation method thereof |
CN108947957A (en) * | 2018-08-16 | 2018-12-07 | 广东丸美生物技术股份有限公司 | A kind of extracting method of mirabalan peel anthocyanidin |
CN110923095A (en) * | 2019-12-20 | 2020-03-27 | 杨伯咸 | Preparation method of red meat cider |
CN111357890B (en) * | 2020-03-05 | 2023-09-22 | 农夫山泉股份有限公司 | Processing method of red-meat apples |
-
2020
- 2020-11-26 CN CN202011347439.3A patent/CN114532466B/en active Active
-
2021
- 2021-11-25 TW TW110143996A patent/TWI802101B/en active
- 2021-11-25 WO PCT/CN2021/133058 patent/WO2022111570A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2022111570A1 (en) | 2022-06-02 |
CN114532466A (en) | 2022-05-27 |
TW202228753A (en) | 2022-08-01 |
CN114532466B (en) | 2023-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101144059B1 (en) | Composition for prevention or treatment of diabete or obesity comprising Punica granatum extract and red ginseng extract | |
TWI802101B (en) | Compositions of red-fleshed apples and cherry plums and their use in lowering blood sugar | |
KR101427784B1 (en) | An anti-diabetes composition comprising Ginseng Radix and mulberry tree extract as effective ingredients | |
KR20140034620A (en) | Composition for preventing or treating diabetbes mellitus disease containing extract of plants | |
KR100699782B1 (en) | Food composition for improving liver function comprising a Lonicera caerulea L. var. edulis extract | |
KR102151011B1 (en) | Composition for preventing, improving or treating liver disease comprising fermented liquor of aged sprout ginseng extract as effective component | |
TW202224699A (en) | Composition of malus neidzwetzkyana dieck and prunus cerasifera ehrhart and use thereof in anti-thrombosis | |
TW202224698A (en) | Composition of niedzwetzky's apple and prunus cerasifera, and application thereof in lowering blood lipid | |
KR20080100942A (en) | Compositions for improving liver function | |
KR20070097868A (en) | Composition comprising an allium cepa l. skin extract for preventing and treating diabetes mellitus | |
KR20140032961A (en) | Composition for preventing and treating diabetes and diabetes complications comprising amphicarpaea edgeworthii var. trisperma powder or an extract thereof | |
KR20130103989A (en) | Composition for the prevention of foods from oxidation and for retarding the onset of diabetes comprsing of the extract of cudrania tricuspidata as a main component | |
KR101350826B1 (en) | Composition for the prevention and treatment of diabetes mellitus comprising extracts or fractions of eremochloa ophiuroides as an active ingredient | |
KR101241455B1 (en) | Bean curd having hypotensive effect | |
KR101041044B1 (en) | A composition for reducing sleep induction time and prolonging sleeping time, and a method for preparing the same | |
JP2020137496A (en) | Composition containing mulberry leaf processed product | |
KR102470108B1 (en) | Composition for Preventing or Treating Diabetes Comprising Butyricimonas Strain as an Active Ingredient | |
KR102203094B1 (en) | Composition for preventing and improving menstrual pain and skin troubles | |
KR102233672B1 (en) | A composition for improving, preventing and treating of diabetes mellitus comprising Milk thistle and Helianthus tuberosus | |
KR101158294B1 (en) | Honey containing roseberry | |
TW200417366A (en) | Remedy | |
US20220133674A1 (en) | Orally ingested composition for improving sleep | |
KR101026857B1 (en) | Composition for preventing or improving the diabete containing eriobotrya japonica extract | |
KR20220117584A (en) | A composition for preventing or improving diabetes containing a radish extract as an active ingredient and a method for producing the same | |
TW202400206A (en) | Composition of Malus niedzwetzkyana Dieck and Prunus cerasifera Ehrhart and use thereof in terms of resisting atherosclerosis |